[go: up one dir, main page]

WO2006088102A1 - Emulsifying agent derived from red yeast - Google Patents

Emulsifying agent derived from red yeast Download PDF

Info

Publication number
WO2006088102A1
WO2006088102A1 PCT/JP2006/302754 JP2006302754W WO2006088102A1 WO 2006088102 A1 WO2006088102 A1 WO 2006088102A1 JP 2006302754 W JP2006302754 W JP 2006302754W WO 2006088102 A1 WO2006088102 A1 WO 2006088102A1
Authority
WO
WIPO (PCT)
Prior art keywords
fat
emulsifier
soluble
water
red yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2006/302754
Other languages
French (fr)
Japanese (ja)
Inventor
Hidehisa Kawahara
Jun Tomono
Hitoshi Obata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaneka Corp
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of WO2006088102A1 publication Critical patent/WO2006088102A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts

Definitions

  • the present invention relates to a novel emulsifier and a water-soluble composition. More specifically, the present invention is obtained from red yeast used as an auxiliary agent in the production of an emulsion that is a mixture of water and fat.
  • the present invention relates to an emulsifier containing a sugar protein complex as a component, a water-soluble composition obtained by using the emulsifier, and a production method thereof.
  • Emulsions in which oil droplets are dispersed in water or in which water droplets are uniformly dispersed constitute foods such as mayonnaise and dressing, and industrial products such as inks and paints. Oil and oil are difficult to mix, so an auxiliary agent is used to emulsify the oil and promote its stability.
  • emulsifiers applied to mammals synthetic emulsifiers such as sugar esters also exist, but it is desired to use natural products for safety, for example, as natural emulsifiers, Proteins such as casein, lipids such as lecithin, or plant polysaccharides such as gum arabic are used.
  • natural emulsifiers Proteins such as casein, lipids such as lecithin, or plant polysaccharides such as gum arabic are used.
  • proteins such as casein
  • lipids such as lecithin
  • plant polysaccharides such as gum arabic
  • alcohols and nonionic emulsifiers are preferred for application to many formulations, particularly mammals, or generally should be approved for use in food.
  • a method for producing a carotenoid emulsion based on glycerin or other polyhydric alcohol and used for filling soft gelatin capsules is described (see Patent Document 4).
  • the emulsifiers used in the examples of the document are likewise nonionic emulsifiers and a relatively low content of active substance is regarded as another drawback.
  • Coenzyme Q10 a type of coenzyme Q known as ubidecarenone or coenzyme Q10, is known as a fat-soluble substance, and there is a technology for maintaining its homogenization and soluble state.
  • a fat emulsion treated with a high pressure homogenizer of the Manton-Gorin type using a nonionic emulsion such as polyethylene glycol and hydrogenated castor oil polyoxyethylene (20) -ether is disclosed (Patent Document). Five).
  • Patent Document 6 an emulsion for intravenous injection that has been treated with a vegetable oil such as soybean oil or a phospholipid emulsifier such as phosphatidylcholine to have a particle size of 0.5 to 300 m is disclosed (Patent Document 6).
  • the fat emulsion has a problem that the particle size is large and the transparency is inferior.
  • the latter intravenous emulsifier has the problem of poor storage stability when the concentration of Coenzyme Q10 is low and high.
  • the water-soluble composition containing Coenzyme Q10 is required to be emulsifiable without the need for oil components, and to be free of special conditions and complicated processes during production.
  • Emulsifiers used in cosmetics are used to blend UV diffusing agents and UV absorbing agents for absorbing UV rays into the skin, and to uniformly disperse UV diffusing agents and UV absorbing agents in cosmetics, etc. Added to. In this case, many emulsifiers are used, and it has been pointed out that when applied directly to the skin and used for a long period of time, it may cause various obstacles. There was a need for an emulsifier.
  • Bathing agents include those containing inorganic salts derived from hot springs as the main component, or those consisting of alkali carbonates and organic acids that generate carbon dioxide in bath water. It is mainly blended.
  • skin bathing effects can be imparted by bath additives, such as those containing a moisturizing component such as polyhydric alcohol, polysaccharides and milk ingredients, those containing plant extracts that are considered to have skin care effects, and those containing oil. Etc.
  • water-soluble moisturizing ingredients are diluted in bath water and are therefore less effective on the skin.
  • Non-Patent Document 1 The cell wall of Saccharomyces cerevisiae contains a substance that is a fusion of mannose and protein. It is known (see Non-Patent Document 1). In this case, the preparation of this substance requires destruction of the cells, which is very laborious and has not been put into practical use.
  • Can dida lipolytics is known to produce substances that have an emulsifying action in the medium! /, And (see Non-Patent Document 2), but it is possible to use poorly soluble carbon sources such as hexadecane during culture. It is necessary, and it has been said that a soluble carbon source such as glucose has a low emulsifying action.
  • Emulsifiers are used in various production processes as well as so-called detergents as indispensable substances in modern life, and are included in various daily products and foods.
  • saponin known as a natural emulsifier
  • Synthetic emulsifiers are generally used as emulsifiers, such as cost and production volume.
  • biotoxicity, environmental persistence, V, and other problems have been pointed out.
  • CMC micelle formation critical concentration
  • biosurfactant producing bacteria There are various microorganisms in nature, some of them have unknown functions, and biosurfactant producing bacteria have been reported.
  • biosurfactants including rhamnolipid (see Non-Patent Document 3) and sopho mouth lipid (see Non-Patent Document 4), have already been put into practical use with increased productivity.
  • those derived from yeast are sophorolipid, which is a glycolipid type for the classification of surfatatant, and this production fungus, Candida bombicola, is a red yeast used in the present invention.
  • the biosurfactants they produce are also different from those of the present invention.
  • Patent Document 1 Japanese Patent Laid-Open No. 47-25220
  • Patent Document 2 Japanese Patent Publication No. 61-260860
  • Patent Document 3 Japanese Patent Publication No. 60-000419
  • Patent Document 4 Japanese Patent Publication No. 58-128141
  • Patent Document 5 Japanese Patent Laid-Open No. 60-199814
  • Patent Document 6 Japanese Patent Laid-Open No. 61-56124
  • Patent Document 7 Japanese Patent Laid-Open No. 4-299940
  • Non-Patent Document 1 D. R. Cameron et al., Applied and Environmental Microbiology, June 1988, p. 1420—1425
  • Non-Patent Document 2 M. C. Cirigliano et al., Applied and Environmental Mi crobiology, Oct. 1984, p. 747—750
  • Non-Patent Document 3 M. Benincasa et al., 2002. J. Food Eng. 54: 283-28 8
  • Non-Patent Document 4 M. Deshpande and L. Daniels, 1995. Bioresour. Techno 1. 53: 143- 150
  • An object of the present invention is to solve the above-mentioned problems and to provide high safety, high safety by itself, a novel emulsifier exhibiting high emulsifiability and emulsification stability, and fat solubility obtained by using the emulsifier. It is to provide a water-soluble composition containing a substance and a method for producing them.
  • the present inventors have added a glycoprotein complex in a culture solution of red yeast to a solution of a fat-soluble substance, thereby homogenizing the fat-soluble substance.
  • the emulsion can be stably emulsified, and it has been found that the emulsification is stable for a long time even after the emulsion is heated, and the present invention has been completed based on this finding.
  • the present invention relates to an emulsifier comprising, as an active ingredient, a sugar protein complex in a culture solution obtained by culturing red yeast in a culture solution.
  • the present invention also relates to a water-soluble composition comprising the above emulsifier and a fat-soluble substance.
  • the present invention relates to a method for producing an emulsifier, characterized by culturing red yeast in a culture solution, and separating and recovering a fraction containing a glycoprotein complex in the obtained culture solution. About.
  • the present invention provides a water-soluble composition characterized by mixing the emulsifier and a fat-soluble substance.
  • the present invention relates to a method for manufacturing a product.
  • the emulsifier of the present invention comprises a sugar protein complex in a culture solution obtained by culturing red yeast in a culture solution as an active ingredient.
  • the red yeast used in the present invention is not particularly limited in terms of its genus and species as long as it is an enzyme mother capable of producing a glycoprotein complex, but its culture is easy and nutritional. Because it can grow from inexpensive materials as a source, Rhodotorula genus, Xanthophyllomyces genus, Rhodospo ridium genus, Candida genus, Saccharomyces genus etc. It is done.
  • Rho dotorula mucilagmosa KUGPP-1 Rhodotorula mucilaginosa NBR C0003, Xanthophyllomyces dendrorhous NBRC10129, Rhodosporidiu m toruloides NBRC0388 and the like are more preferably used because they produce a large amount of an emulsifying substance. It is done.
  • the red yeast can be used alone or in combination of two or more.
  • Rhodotorula mucilaginosa KUGPP-1 was separated from Antarctica and was deposited with an accession number of FERM BP-10500 on February 2, 2006 (the original deposit on February 8, 2005 was transferred to an international deposit) In addition, it is deposited at the Patent Organism Depositary, National Institute of Advanced Industrial Science and Technology, located in 1st, 1st, 1st, Tsukuba, Higashi, Ibaraki, Japan.
  • the other red yeast can be obtained from NBRC (Biotechnology Division, Biotechnology Headquarters, National Institute of Technology and Evaluation).
  • the red yeast is easily cultivated and has properties suitable for culturing in large quantities to produce a glycoprotein complex that is an aggregation inhibitor (emulsifying component). That is, the red yeast is a fraction (glycoprotein complex) that grows well in a medium consisting only of inorganic salts containing glucose as the only carbon source and can be precipitated and concentrated with acetone or the like in the culture medium. Have a strong emulsifying activity.
  • the culture is carried out in a medium usually used for culturing microorganisms. It ’s fine.
  • Glucose is preferably used as a carbon source necessary for the growth of red yeast contained in the medium.
  • the concentration is preferably about 0.1 to 5% by volume, more preferably about 0.5 to 1.5% by volume.
  • alcohols such as ethanol and oils such as corn oil and soybean oil can be used as the carbon source instead of glucose.
  • ammonium salt is preferably used, and ammonium phosphate is particularly preferable from the viewpoint of pH buffering ability and replenishment of phosphorus content.
  • the pH of the medium decreases as the culture progresses, it is possible to carry out the culture by adding alkali dropwise, preferably adjusting the pH to 6 to 8, more preferably pH 6.5 to 7.5. I like it.
  • alkali such as sodium hydroxide, potassium hydroxide, ammonia, and an amine compound can be used as the alkali used in this case, but ammonia is preferably used in terms of supplying a nitrogen source for cell growth. .
  • yeast extract may be added to the medium to supplement vitamins and the like.
  • the glucose of the carbon source gradually decreases as the cell grows, the force that needs to be gradually added can be added at this time.
  • a mixture of ammonia and ethanol can also be added.
  • any method such as a method of intermittently adding a certain amount or a method of adding continuously can be adopted.
  • the surface force of the cell growth rate is usually a force of 0 to 50 ° C, more preferably around 25 to 35 ° C.
  • the culture time is not particularly limited, but is preferably 12 to 70 hours, more preferably 24 to 48 hours.
  • agitation culture or stationary culture can be employed, and either aeration culture or closed culture may be used, but in order to accelerate the growth of microorganisms, agitation culture is preferably performed under aeration.
  • the fraction containing the glycoprotein complex is separated and recovered. Centrifugation of red yeast cells prior to separation and collection It can also be removed in advance from the culture medium by an operation such as separation, or the culture supernatant can be used.
  • Glycoprotein complexes can be separated and recovered by methods using quaternary amines such as cetyl pyridinium hydrochloride and cetyltributyl odor, lower alcohols such as methanol, ethanol and isopropanol, and acetone.
  • quaternary amines such as cetyl pyridinium hydrochloride and cetyltributyl odor
  • lower alcohols such as methanol, ethanol and isopropanol
  • acetone acetone
  • glycoprotein complex separated and recovered by the above method is used as a powder dried by a known method, or again dissolved in water and used as an aqueous solution.
  • fractionation based on affinity such as ion exchange column and affinity column
  • fractionation based on molecular weight such as ultrafiltration and gel filtration column.
  • the glycoprotein complex contained as an active ingredient in the emulsifier of the present invention is a high-molecular sugar protein complex secreted from cells of red yeast into the culture medium by culturing the red yeast. It is.
  • the glycoprotein complex is produced in the culture solution, the action as an emulsifier is remarkable, and the glycoprotein complex is recovered from the culture solution after the red yeast is produced. Separation from red yeast cells is easy.
  • the glycoprotein complex one that is secreted by red yeast cells into the culture medium by culturing the red yeast can be used. In addition, it can be used even if it stays in the cell wall or cells before being secreted.
  • the glycoprotein complex is a complex having a sugar and a protein, and refers to a glycoprotein in which a sugar and a protein are combined, or a group of substances in which lipids or the like are added to the glycoprotein. It is not limited.
  • Sugar refers to one or more oligosaccharides, and also includes a repeating structure of a specific sugar.
  • the protein part has two or more amino acid forces.
  • the glycoprotein complex can be used alone or in combination of two or more.
  • the glycoprotein complex preferably has an average molecular weight of 30,000 or more. That is, the molecular weight shown by gel filtration of the fraction containing the glycoprotein complex is preferably 30,000 or more.
  • the average molecular weight can be determined by a known method such as laser scatterometer or gel filtration. In the present invention, it was determined by gel filtration as described in the examples below. That is, the average molecular weight can be measured using the obtained glycoprotein complex as a gel filtration carrier (Sephacryl S-400HR, ⁇ lcm X length 100 cm) and using dextran as a molecular weight marker.
  • a gel filtration carrier Sephacryl S-400HR, ⁇ lcm X length 100 cm
  • the other components in the emulsifier include red yeast culture fluid components other than the glycoprotein complex, and various additives may be added to enhance the effect as an emulsifier.
  • An agent may be used.
  • a stabilizer is used or the actual use is facilitated.
  • a liquid such as water can be used.
  • an antioxidant for example, an antioxidant, an antiseptic, a cosmetic active agent, a humidifier, a sphingolipid, a fat-soluble polymer and the like may be contained.
  • an existing emulsifier can be used in combination.
  • the dosage form of the emulsifier may be either liquid or solid, but is in contact with a fat-soluble substance. In order to mix the emulsifier and the fat-soluble substance uniformly, it is preferable to use liquid form.
  • the content of the glycoprotein complex in the emulsifier is not particularly limited, but 0.0001 to 10% by weight of the total emulsifier is preferable, and 0.001 to 1% by weight is more preferable. That's right.
  • the method for producing an emulsifier of the present invention is characterized in that red yeast is cultured in a culture solution, and a fraction containing the glycoprotein complex in the obtained culture solution is separated and recovered. Specifically, it is as described above.
  • the present invention relates to a water-soluble composition containing a fat-soluble substance obtained by contacting an oil-soluble substance with an emulsifier containing a glycoprotein complex produced by the red yeast! Explain in an instant.
  • the water-soluble composition of the present invention contains the emulsifier and the fat-soluble substance.
  • the fat-soluble substance used in the present invention is not particularly limited as long as it is physiologically acceptable.
  • fat-soluble drugs such as Coenzyme Q10; fat-soluble vitamins A, D, E, K, and Vitamins such as derivatives thereof; essential oil (for example, pine oil, lime oil, yuzu oil), vegetable oil (for example, soybean oil, rapeseed oil, bean flower oil, corn oil, sesame oil, cottonseed oil, olive oil, palm oil, sunflower oil Oils such as beef tallow, lard, etc .; fat-soluble pigments (eg, Anato, Tucon, Benikouji, chlorophyll, etc.); perfumes (eg, orange oil); carotenoids (eg, canthaxanthin Astaxanthin, zeaxanthin, lycopene, apocarotinanol, ⁇ -strength rotin, etc.).
  • essential oil for example, pine oil, lime oil, yuzu oil
  • vegetable oil for example,
  • These fat-soluble substances can be used alone or in combination of two or more.
  • the water-soluble composition of the present invention can contain various components such as pigments, seasonings, antibacterial agents, and the like, in addition to the additives exemplified in the above-mentioned emulsifiers, foods, cosmetics, bathing agents. Various performances as industrial products including the above can be imparted.
  • water a solvent such as alcohol such as ethanol is added to the water-soluble composition.
  • a solvent such as alcohol such as ethanol is added to the water-soluble composition.
  • the content of the glycoprotein complex in the water-soluble composition is not particularly limited, but 0.0001% to 10% by weight of the whole water-soluble composition is preferable. 0.001% to 1% by weight is more preferred.
  • the content of the fat-soluble substance is not particularly limited, but 0.001 to 30% by weight of the entire water-soluble composition is preferable, and 0.001 to 10% by weight is more preferable.
  • the method for producing a water-soluble composition of the present invention is characterized by mixing the emulsifier and the fat-soluble substance.
  • an emulsifier and a fat-soluble substance are brought into contact with each other, and both are mixed.
  • the mixing method is not particularly limited as long as both can be sufficiently brought into contact with each other, such as shaking and stirring.
  • stirring is performed in order to quickly and sufficiently mix a material having a relatively high viscosity such as a fat-soluble substance.
  • stirring is performed in order to quickly and sufficiently mix a material having a relatively high viscosity such as a fat-soluble substance.
  • known methods such as a method using a milling blender and a juicer, a method using a Manton-Gorin homogenizer, and a method using ultrasonic waves can be used.
  • heat may be generated during mixing, so when using a material that does not have enough heat resistance, it is necessary to mix carefully so as not to reach a high temperature.
  • volatile solvents such as paints are included, the latter does not cause microbial growth. It should be done in a short time so that the solvent will volatilize!
  • both when adding an emulsifier to a fat-soluble substance, both may be mixed after adding them at the same time 1S Add both of them gradually and mix them, or gradually add one to the other. Any form such as mixing can be adopted.
  • the invention's effect [0043] According to the present invention, a novel emulsifier having high safety and high emulsifiability and emulsification stability can be obtained, and a fat-soluble substance stably emulsified by using the emulsifier. It is possible to obtain a water-soluble composition containing benzene, and the contribution to the industry is very large.
  • Example 1 Preparation of crude emulsifier derived from yeast culture solution
  • the supernatant was concentrated at about 30 m using an ultrafiltration membrane with a cutoff value of MW 100,000. Thereafter, dialysis was performed against buffer A [20 mM potassium phosphate buffer (pH 7.0)], and this was used as a crude emulsifier (sample A).
  • this emulsifier was determined by adding sample 100 1 to 1.8 ml of Buffer A and dissolving it in dimethyl sulfoxide to 200 ⁇ g Zml (Wax Junyaku Co., Ltd.). ) was added and mixed well, and the index was that it did not aggregate after standing at about 26 ° C for 15 minutes. In other words, if it does not aggregate after standing at about 26 ° C for 15 minutes, it has emulsification activity.
  • the amount of sugar (converted to glucose) was determined using the phenol-sulfuric acid method, and the amount of protein (converted to BSA) was determined using the BCA kit (PIERCE).
  • the total amount of sugar was 2.6 mg.
  • the total protein amount was 0.3 mg. From this, it was found that this emulsifier contains sugar and protein in a ratio of about 9: 1.
  • Example 2 Evaluation of emulsifying action
  • Example 2 Add 100 1 of sample A prepared in Example 1 to 1.8 ml of Buffer A [20 mM phosphate buffer (PH 7.0)], and add 200 gZml in dimethyl sulfoxide. 1001 of wastaxanthin (manufactured by Wako Pure Chemical Industries, Ltd.) dissolved in 1 was added and mixed well. As a control, a culture solution of Saccharomyces cerevisiae NBRC223 prepared according to Example 1 was used.
  • Example 3 Purification of emulsifying agent
  • Sample A prepared in Example 1 is filled with 30 ml of DEAE—TOYOPEARL650M (manufactured by Tosohichi Co., Ltd.), which is an anion exchange resin that has been equilibrated in advance with buffer B [20 mM Tris-HCl buffer (pH 8.0)].
  • buffer B 20 mM Tris-HCl buffer (pH 8.0)
  • Column ⁇ 1.6 cm x 10 cm
  • eluting with sodium chloride linear gradient method total elution volume 760 ml
  • sodium chloride concentration from 300 mM to 400 mM
  • About 20 ml of the emulsifying active fraction eluted during the period was recovered.
  • This fraction was concentrated to about 2 ml using a centrifugal ultrafiltration membrane Centrivep-10 (Amicon). This was subjected to gel filtration using a column ( ⁇ 1.6 cm ⁇ 100 cm) packed with Superose 12 (manufactured by Pharmacia) equilibrated with buffer C [50 mM potassium phosphate buffer (pH 7.0)] About 2 ml of active fraction (emulsifying agent) was obtained.
  • ProteinaseK manufactured by SIGMA was prepared to 200 UZml.
  • the emulsifying agent was considered to be a glycoprotein.
  • Example 4 Measurement of molecular weight of emulsifying agent
  • Example 5 Emulsifying action of ⁇ -carotene, vitamins ( ⁇ , ⁇ , ⁇ ) and Coenzyme Q10
  • Emulsifying agent 100 1 prepared in Example 3 was added to 0.9 ml of 10 mM potassium phosphate buffer (pH 7.0), 10 mg of carotene (manufactured by Nacalai Testa), vitamin A (Nacalai Tester) ), Vitamin E (manufactured by Nacalai Testa), vitamin K1 (manufactured by Nacalai Testa), and Coenzyme Q10, and mixed well.
  • a culture solution of Sacc haromyces cerevisiae NBRC223 prepared according to Example 1 was used.
  • Example 6 Emulsification of other red yeast cultures
  • Rhodotorula mucilagino a red yeast
  • YM medium in 100 ml of YM medium in a test tube sa NBRC0003, Xanthophyllomyces dendrorhous NBRC10129, Rhodos poridium toruloides NBRC0388, respectively, and cultured at 30 ° C, 120rpm for 48 hours.
  • About 100 ml of supernatant was collected. This fraction was concentrated to about 10 ml using a centrifugal ultrafiltration membrane Centrivep-10 (Amicon), and this was used as a crude emulsifier.
  • Example 5 In the same manner as in Example 2, the emulsifying effect on wastaxanthin and in the same manner as in Example 5, the emulsifying effect on j8-carotene, vitamins (A, E, K), and Coenzyme Q10 were evaluated. As a result, an emulsifying action was observed in all strains.
  • Sample B prepared in Example 1 was mixed with 50 mM sodium acetate buffer at pH 5 and 6, 50 mM potassium phosphate buffer at pH 6, 7 and 8, 50 mM Tris buffer at pH 8 and 9, 5 OmM sodium carbonate at pH 9 and 10. After dialyzing with buffer solution, add 100 1 of sample B to a final concentration of 10 / z gZml, 1. Carry it with 8 ml of each pH buffer solution, and add 200 ⁇ l to dimethylsulfoxide. Axaxanthin (manufactured by Wako Pure Chemical Industries) dissolved in gZml was added at 100 / zl and mixed well.
  • the emulsifier of the present invention is effective over a wide pH range.
  • Example 8 Strength of emulsifying action (using aastaxanthin)
  • the emulsifier of sample C stably emulsified the astaxanthin even at a low concentration, whereas surfatatin Na aggregated the atastaxanthin at a low concentration (the absolute value of the absorbance of astaxanthin decreased) . That is, it became clear that the emulsifier of the present invention exhibits a higher emulsifying action than is surfatatin Na against wastaxanthin.
  • Example 9 Effect of suppressing dye fading
  • sample C containing 100 1 of buffer A instead of surfatatin Na was used as a control, and the spectrum was measured immediately after the addition of astaxanthin and used as a comparative control.
  • Data 1 is for control (immediately after addition)
  • data 2 is for sample C (after storage at 26 ° C for 1 month)
  • data 3 is for surfatatin Na (after storage at 26 ° C for 1 month) .
  • the absorption spectrum of istaxanthin is unchanged and stable.
  • the absorption spectrum is changed because astaxanthin aggregates.
  • the color tone changed over time. That is, the present invention It was found that the emulsifier retained the color immediately after addition even after being left for 1 month.
  • FIG. 1 is a graph showing the pH stability of an emulsifier.
  • FIG. 2 is a graph showing the effect of suppressing dye fading.
  • FIG. 3 is a graph of sugar composition analysis.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

A novel emulsifying agent that is highly safe, exhibiting alone high emulsifying capability and emulsification stability; a water-soluble composition containing a lipid-soluble substance obtained by the use of the emulsifying agent; and processes for producing them. There is provided an emulsifying agent comprising as an active ingredient a glycoprotein complex contained in the culture fluid obtained by culturing red yeast in a culture fluid. Further, there is provided a water-soluble composition comprising the emulsifying agent and a lipid-soluble substance. Still further, there are provided processes for producing the emulsifying agent and the water-soluble composition.

Description

明 細 書  Specification

赤色酵母由来の乳化剤  Emulsifier derived from red yeast

技術分野  Technical field

[0001] 本発明は、新規な乳化剤及び水溶性組成物に関し、さら〖こ詳しくは、水と油脂の混 合物である乳化物を製造する際に助剤として用いられる、赤色酵母より得られる糖タ ンパク質複合体を成分として含む乳化剤、これを用いて得られる水溶性組成物、及 び、これらの製造方法に関するものである。  [0001] The present invention relates to a novel emulsifier and a water-soluble composition. More specifically, the present invention is obtained from red yeast used as an auxiliary agent in the production of an emulsion that is a mixture of water and fat. The present invention relates to an emulsifier containing a sugar protein complex as a component, a water-soluble composition obtained by using the emulsifier, and a production method thereof.

背景技術  Background art

[0002] 水中に油滴をあるいは油中に水滴を均一に分散させた乳化物は、マヨネーズ、ドレツ シング等の食品、インクや塗料等の工業製品等を構成するものであるが、元来水と油 は混合しにくぐそのためこれを乳化し、さらにその安定ィ匕を促すための助剤が利用 される。  [0002] Emulsions in which oil droplets are dispersed in water or in which water droplets are uniformly dispersed constitute foods such as mayonnaise and dressing, and industrial products such as inks and paints. Oil and oil are difficult to mix, so an auxiliary agent is used to emulsify the oil and promote its stability.

[0003] 従来より、こうした工業用乳化剤としては、有機合成的に得られるアルキル硫酸塩や ポリオキシエチレン系の低分子量の合成乳化剤等が利用されてきたが、これらは微 生物による分解を受けにくぐ環境中に放出された際に生分解を受けずに環境中に 蓄積し、汚染を引き起こす可能性が指摘されている。また、従来力 有機性の溶剤に 溶力して用いられてきた塗料等にも同様の環境汚染の危惧があり、さらには作業上 の安全性の見地から、用いられる溶剤を水へと転換することが望まれて ヽる。  [0003] Conventionally, as such industrial emulsifiers, alkyl sulfates obtained by organic synthesis, polyoxyethylene-based low molecular weight synthetic emulsifiers, and the like have been used, but these are subject to degradation by microorganisms. It has been pointed out that when it is released into the environment, it may accumulate in the environment without undergoing biodegradation, causing pollution. In addition, paints that have been used by dissolving in conventional organic solvents have similar environmental pollution concerns, and from the viewpoint of work safety, the solvent used is converted to water. It is hoped for.

[0004] これに対応するために、例えば、塗料等を利用するにあたり、塗布後の塗布部での 液だれを防止するために、塗料等に一定の粘性を付与する必要があった力 従来よ り用いられていた乳化剤では粘性が不十分であり、別に増粘剤を添加する必要があ るため、より多くの組成となり、製造上あるいは経済的にも問題を有していた。  [0004] In order to cope with this, for example, when using paint or the like, it was necessary to apply a certain viscosity to the paint or the like in order to prevent dripping at the application part after application. The emulsifiers used in the past had insufficient viscosity, and it was necessary to add a thickener separately, which resulted in a larger composition and had problems in production and economy.

[0005] また、哺乳動物に適用される乳化剤としては、シュガーエステル等の合成乳化剤も存 在するが、その安全面力 天然物を利用することが望まれており、例えば、天然乳化 剤として、カゼイン等の蛋白質、レシチン等の脂質、あるいはアラビアガムのような植 物多糖が利用されている。しかしながら、これらは、乳化性は高いものの、溶液の粘 性が低いために長時間放置すると水相と油相が分離してしまうという欠点があった。 この問題を解決するために、これらの乳化剤を多量に添加する力、あるいはキサンタ ン等の増粘剤との併用による安定ィ匕が必要となり、経済上あるいは製造上の課題を 有していた。また、アラビアガムは植物由来であるため、その生産量が気候等に左右 されやすぐ安定的に供給することが難しいという課題もあった。 [0005] Further, as emulsifiers applied to mammals, synthetic emulsifiers such as sugar esters also exist, but it is desired to use natural products for safety, for example, as natural emulsifiers, Proteins such as casein, lipids such as lecithin, or plant polysaccharides such as gum arabic are used. However, although these have high emulsifiability, they have a drawback that the aqueous phase and the oil phase are separated when left for a long time due to the low viscosity of the solution. In order to solve this problem, the ability to add a large amount of these emulsifiers or the stability by using in combination with a thickener such as xanthan is necessary, which has economic and manufacturing problems. Another problem is that gum arabic is derived from plants and its production is influenced by the climate and it is difficult to supply it quickly and stably.

[0006] カロチノイド又はビタミンを含有するェマルジヨン中でポリアルコールを使用することが 記載されている他の特許明細書では、アルコール、例えばエタノール (特許文献 1参 照)、非イオン性乳化剤、例えばポリグリセリン脂肪酸エステル、(特許文献 2参照)又 はその両方 (特許文献 3参照)を付加的に使用することが必要である。  [0006] Other patent specifications that describe the use of polyalcohols in emulsions containing carotenoids or vitamins include alcohols such as ethanol (see Patent Document 1), nonionic emulsifiers such as polyglycerin. It is necessary to additionally use fatty acid esters (see patent document 2) or both (see patent document 3).

[0007] しかしながら、アルコール及び非イオン性乳化剤は、多くの製剤、特に哺乳動物に適 用するために好ましくな 、か、又は一般的に食品中での使用は認可されて ヽな 、。 更に、グリセリン又はその他の多価アルコールをベースとし、軟質のゼラチンカプセ ルに充填するために使用されるカロチノィドエマルジヨンの製造方法 (特許文献 4参 照)が記載されている。当該文献の実施例で使用された乳化剤は、同様に非イオン 性乳化剤であり、かつ比較的低い活性物質の含量がもう 1つの欠点とみなされる。  [0007] However, alcohols and nonionic emulsifiers are preferred for application to many formulations, particularly mammals, or generally should be approved for use in food. Furthermore, a method for producing a carotenoid emulsion based on glycerin or other polyhydric alcohol and used for filling soft gelatin capsules is described (see Patent Document 4). The emulsifiers used in the examples of the document are likewise nonionic emulsifiers and a relatively low content of active substance is regarded as another drawback.

[0008] ュビデカレノン又は補酵素 Q 10として知られている補酵素 Qの 1種であるコェンザィ ム Q10は、脂溶性物質として知られ、その均質化、可溶ィ匕状態を保持させるための 技術が開発されている。例えば、ポリエチレングリコール、硬化ヒマシ油ポリオキシェ チレン一(20)—エーテル等の非イオン乳ィ匕剤を用いて、マントンーゴーリン型の高 圧ホモジナイザーで処理された脂肪乳剤が開示されている (特許文献 5)。また、大 豆油等の植物油、ホスファチジルコリン等のリン脂質乳化剤を用いて処理し、粒径を 0. 5〜300 mとした静注用乳化液が開示されている(特許文献 6)。  [0008] Coenzyme Q10, a type of coenzyme Q known as ubidecarenone or coenzyme Q10, is known as a fat-soluble substance, and there is a technology for maintaining its homogenization and soluble state. Has been developed. For example, a fat emulsion treated with a high pressure homogenizer of the Manton-Gorin type using a nonionic emulsion such as polyethylene glycol and hydrogenated castor oil polyoxyethylene (20) -ether is disclosed (Patent Document). Five). In addition, an emulsion for intravenous injection that has been treated with a vegetable oil such as soybean oil or a phospholipid emulsifier such as phosphatidylcholine to have a particle size of 0.5 to 300 m is disclosed (Patent Document 6).

ところが、前者の方法では、脂肪乳剤は、粒径が大きく透明感で劣る問題がある。さ らに、後者の静注用乳化剤は、コェンザィム Q10の含有量が少なぐ高濃度にした 場合に保存安定性が悪い問題がある。コェンザィム Q 10を含有する水溶性組成物と しては、油成分を必要としないで乳化できる、製造の際に特殊な条件、複雑な工程 等が不要であること等が求められて 、る。  However, in the former method, the fat emulsion has a problem that the particle size is large and the transparency is inferior. Furthermore, the latter intravenous emulsifier has the problem of poor storage stability when the concentration of Coenzyme Q10 is low and high. The water-soluble composition containing Coenzyme Q10 is required to be emulsifiable without the need for oil components, and to be free of special conditions and complicated processes during production.

[0009] また食品の製造工程においては、缶詰等、製造工程で加熱処理を受ける食品に、脂 溶性天然物を添加しょうとする場合、加熱により乳化が破壊され、脂溶性天然物が表 面に浮上する現象としてタリーミングが発生するという問題点があった。この問題点を クリアするために、ショ糖縮合リシノール酸エステルとアルコールを用いて耐熱性乳化 を試みている(特許文献 7)。しかし、上記の先行技術も缶コーヒーのレトルト処理 (一 般的には 125°C、 20分)等、加熱条件が厳しい場合には乳化が破壊され、タリーミン グが発生する。そのため、より熱に強い乳化剤が求められている。 [0009] In addition, in a food manufacturing process, when trying to add a fat-soluble natural product to food that is heat-treated in the manufacturing process, such as canned food, the emulsion is destroyed by heating, and the fat-soluble natural product is displayed. There was a problem that tallying occurred as a phenomenon that surfaced. In order to clear this problem, heat-resistant emulsification is attempted using sucrose condensed ricinoleic acid ester and alcohol (Patent Document 7). However, in the above prior art, if the heating conditions are severe, such as retorting of canned coffee (generally 125 ° C, 20 minutes), the emulsification is destroyed and taring occurs. Therefore, there is a demand for an emulsifier that is more resistant to heat.

[0010] 化粧品に用いられる乳化剤は、紫外線を吸収させる為の紫外線拡散剤や紫外線吸 収剤を肌になじませる為、また、化粧品内で紫外線拡散剤や紫外線吸収剤を均一に 分散させる為等に加えられる。この場合、乳化剤が多く使用されており、直接肌に塗 布し、長期間使用する場合は様々な障害を生じる可能性が指摘されており、このこと 力も化粧品用途においても肌にやさしい天然由来の乳化剤が求められていた。  [0010] Emulsifiers used in cosmetics are used to blend UV diffusing agents and UV absorbing agents for absorbing UV rays into the skin, and to uniformly disperse UV diffusing agents and UV absorbing agents in cosmetics, etc. Added to. In this case, many emulsifiers are used, and it has been pointed out that when applied directly to the skin and used for a long period of time, it may cause various obstacles. There was a need for an emulsifier.

[0011] 入浴剤は、温泉由来の無機塩類を主成分としたものや、炭酸アルカリ塩と有機酸か らなり浴湯中で炭酸ガスを発生するものに、香料や着色料、植物エキス等を配合した ものが主体である。近年では、入浴によるスキンケア効果に関心が高まり、スキンケア 効果を付与した入浴剤の提案が多くなされるようになつてきた。入浴剤によってスキン ケア効果を付与する方法としては多価アルコール、多糖類やミルク成分等の保湿成 分を配合したもの、スキンケア効果のあるとされる植物エキスを配合したもの、油分を 配合したもの等がある。しかし、水溶性の保湿成分は浴湯中に希薄に溶けてしまうた め皮膚に残りにくく効果が弱 、。また効果が期待できるほど多量に用いることは湯上 力 Sり後の肌のベたつき等の原因になったり経済的でない等、不具合である。それに 対し、油分を用いるものは比較的少量の使用で効果や実感が得られ有効な手段で あり、油分を乳化剤により浴湯中に乳化するタイプ等が通常用いられる。しかし油分 の配合量には限度があり、入れすぎると製剤の流動性が悪くなり製剤化に支障を来 すため、より少量で効果的な乳化剤が必要とされていた。また入浴時には多量の水 を使用し多量の乳化剤を必要とするため、安全性にも問題が生じることが予想され、 天然由来の乳化剤が求められていた。  [0011] Bathing agents include those containing inorganic salts derived from hot springs as the main component, or those consisting of alkali carbonates and organic acids that generate carbon dioxide in bath water. It is mainly blended. In recent years, interest in the skin care effect of bathing has increased, and many proposals have been made for bathing agents that have been given skin care effects. Skin bathing effects can be imparted by bath additives, such as those containing a moisturizing component such as polyhydric alcohol, polysaccharides and milk ingredients, those containing plant extracts that are considered to have skin care effects, and those containing oil. Etc. However, water-soluble moisturizing ingredients are diluted in bath water and are therefore less effective on the skin. In addition, the use of such a large amount that the effect can be expected is a problem such as causing skin stickiness after hot water force S and not being economical. On the other hand, those that use oil are effective means that achieve effects and real feelings when used in relatively small amounts, and a type in which oil is emulsified in a bath with an emulsifier is usually used. However, there is a limit to the amount of oil that can be added, and if it is added too much, the fluidity of the preparation deteriorates and hinders formulation. Therefore, a smaller amount of an effective emulsifier is required. In addition, since a large amount of water is used at the time of bathing and a large amount of emulsifier is required, it is anticipated that there will be problems with safety, and naturally derived emulsifiers have been demanded.

[0012] こういった理由から、従来より天然由来の乳化剤が求められており、生物材料からの 乳化剤としては、以下のようなものの報告がある。 Saccharomyces cerevisiaeの細 胞壁にはマンノースとタンパク質の融合した物質が含まれ、これが乳化作用を示すこ とが知られている (非特許文献 1参照)。この場合、この物質の調製には菌体を破壊 せねばならず、非常に手間が力かるものであり、実用化には至っていない。また Can dida lipolyticsでは培地中に乳化作用を示す物質を生産することが知られて!/、る ( 非特許文献 2参照)が、へキサデカン等、難溶性の炭素源を培養時に使用することが 必要であり、グルコース等の溶解性の炭素源では、その乳化作用が低いことが難点 であるとされていた。 For these reasons, naturally-derived emulsifiers have been conventionally demanded, and the following are reported as emulsifiers from biological materials. The cell wall of Saccharomyces cerevisiae contains a substance that is a fusion of mannose and protein. It is known (see Non-Patent Document 1). In this case, the preparation of this substance requires destruction of the cells, which is very laborious and has not been put into practical use. In addition, Can dida lipolytics is known to produce substances that have an emulsifying action in the medium! /, And (see Non-Patent Document 2), but it is possible to use poorly soluble carbon sources such as hexadecane during culture. It is necessary, and it has been said that a soluble carbon source such as glucose has a low emulsifying action.

[0013] 乳化剤は、現代生活には欠力せない物質としていわゆる洗剤の他、様々な生産過程 で使用されるとともに、様々な日用製品や食品中に含まれている。特に、天然の乳化 剤として知られたサポニンゃ 、わゆる石鹼の使用は歴史的にも長 、が、天然の乳化 剤はその界面活性能力や生産性力も用途が限定されている。乳化剤としては、コスト や生産量等力 一般に合成乳化剤が用いられているが、生物毒性や環境残留性と V、つた問題が指摘されて 、る。  [0013] Emulsifiers are used in various production processes as well as so-called detergents as indispensable substances in modern life, and are included in various daily products and foods. In particular, saponin, known as a natural emulsifier, has been used for a long time, and the use of natural emulsifiers is limited in its surface activity and productivity. Synthetic emulsifiers are generally used as emulsifiers, such as cost and production volume. However, biotoxicity, environmental persistence, V, and other problems have been pointed out.

[0014] 一方、微生物由来の様々な乳化剤様物質が報告されており、これらはバイオサーフ ァクタントと称されるが、ミセル形成臨界濃度 (CMC)が合成洗剤に比べて低ぐ生物 毒性や環境残留性がないといった長所を有している。また、培養により大量生産する ことができると!/、つた特徴も有して!/、る。  [0014] On the other hand, various emulsifier-like substances derived from microorganisms have been reported, and these are called biosurfactants, but their biotoxicity and environmental residues are low in micelle formation critical concentration (CMC) compared to synthetic detergents. It has the advantage of not having sex. It can also be mass-produced by culture! /

自然界には様々な微生物が存在し、それらの中には未知の機能を持つものが含ま れており、バイオサーファタタント生産菌も報告されている。ラムノリピド (非特許文献 3 参照)や、ソフォ口リピド (非特許文献 4参照)を含む 、くつかのバイオサーファタタント は、生産性を上げて既に実用化されている。これらの中で酵母由来のものでは、ソフ ォロリピッドであるが、これはサーファタタントの分類上、糖脂質型であり、またこの生 産菌である Candida bombicolaは、本発明で用いる赤色酵母とは分類学上異なり 、これらが産生するバイオサーファクタントも本発明のものとは異なる。  There are various microorganisms in nature, some of them have unknown functions, and biosurfactant producing bacteria have been reported. Several biosurfactants, including rhamnolipid (see Non-Patent Document 3) and sopho mouth lipid (see Non-Patent Document 4), have already been put into practical use with increased productivity. Among these, those derived from yeast are sophorolipid, which is a glycolipid type for the classification of surfatatant, and this production fungus, Candida bombicola, is a red yeast used in the present invention. Different in taxonomy, the biosurfactants they produce are also different from those of the present invention.

特許文献 1:特開昭 47 - 25220号公報  Patent Document 1: Japanese Patent Laid-Open No. 47-25220

特許文献 2:特公昭 61— 260860号公報  Patent Document 2: Japanese Patent Publication No. 61-260860

特許文献 3:特公昭 60— 000419号公報  Patent Document 3: Japanese Patent Publication No. 60-000419

特許文献 4:特公昭 58 - 128141号公報  Patent Document 4: Japanese Patent Publication No. 58-128141

特許文献 5:特開昭 60 - 199814号公報 特許文献 6:特開昭 61— 56124号公報 Patent Document 5: Japanese Patent Laid-Open No. 60-199814 Patent Document 6: Japanese Patent Laid-Open No. 61-56124

特許文献 7:特開平 4— 299940号公報  Patent Document 7: Japanese Patent Laid-Open No. 4-299940

非特許文献 1 : D. R. Cameron et al. , Applied and Environmental Micr obiology, June 1988, p. 1420— 1425  Non-Patent Document 1: D. R. Cameron et al., Applied and Environmental Microbiology, June 1988, p. 1420—1425

非特許文献 2 : M. C. Cirigliano et al. , Applied and Environmental Mi crobiology, Oct. 1984, p. 747— 750  Non-Patent Document 2: M. C. Cirigliano et al., Applied and Environmental Mi crobiology, Oct. 1984, p. 747—750

非特許文献 3 : M. Benincasa et al. , 2002. J. Food Eng. 54 : 283- 28 8  Non-Patent Document 3: M. Benincasa et al., 2002. J. Food Eng. 54: 283-28 8

非特許文献 4: M. Deshpande and L. Daniels, 1995. Bioresour. Techno 1. 53 : 143- 150  Non-Patent Document 4: M. Deshpande and L. Daniels, 1995. Bioresour. Techno 1. 53: 143- 150

発明の開示  Disclosure of the invention

発明が解決しょうとする課題  Problems to be solved by the invention

[0015] 本発明の目的は、上記の問題を解決し、安全性の高!ヽ、単独で高!ヽ乳化性と乳化 安定性を示す新規な乳化剤、当該乳化剤を用いることで得られる脂溶性物質を含有 する水溶性組成物、及び、これらの製造法を提供することである。 [0015] An object of the present invention is to solve the above-mentioned problems and to provide high safety, high safety by itself, a novel emulsifier exhibiting high emulsifiability and emulsification stability, and fat solubility obtained by using the emulsifier. It is to provide a water-soluble composition containing a substance and a method for producing them.

課題を解決するための手段  Means for solving the problem

[0016] 本発明者らは、上記課題を解決すべく鋭意研究した結果、赤色酵母の培養液中の 糖タンパク質複合体を脂溶性物質の溶液に添加したところ、脂溶性物質を均質化す ることによって、安定に乳化させることができ、この乳化液を加熱処理した後も乳化が 長期間安定であることを見い出し、この知見に基づき本発明を完成するに至った。  [0016] As a result of intensive studies to solve the above-mentioned problems, the present inventors have added a glycoprotein complex in a culture solution of red yeast to a solution of a fat-soluble substance, thereby homogenizing the fat-soluble substance. Thus, the emulsion can be stably emulsified, and it has been found that the emulsification is stable for a long time even after the emulsion is heated, and the present invention has been completed based on this finding.

[0017] すなわち、本発明は、赤色酵母を培養液中で培養して得られる培養液中の糖タンパ ク質複合体を、有効成分として含有してなる乳化剤に関する。  That is, the present invention relates to an emulsifier comprising, as an active ingredient, a sugar protein complex in a culture solution obtained by culturing red yeast in a culture solution.

また、本発明は、上記乳化剤及び脂溶性物質を含有してなる水溶性組成物に関す る。  The present invention also relates to a water-soluble composition comprising the above emulsifier and a fat-soluble substance.

さら〖こ、本発明は、赤色酵母を培養液中で培養し、得られた培養液中の糖タンパク 質複合体を含有する画分を分離及び回収することを特徴とする、乳化剤の製造方法 に関する。  Further, the present invention relates to a method for producing an emulsifier, characterized by culturing red yeast in a culture solution, and separating and recovering a fraction containing a glycoprotein complex in the obtained culture solution. About.

また、本発明は、上記乳化剤と脂溶性物質を混合することを特徴とする、水溶性組成 物の製造方法に関する。 Further, the present invention provides a water-soluble composition characterized by mixing the emulsifier and a fat-soluble substance. The present invention relates to a method for manufacturing a product.

[0018] 以下に、本発明を詳細に説明する。  [0018] The present invention is described in detail below.

まず、本発明の乳化剤は、赤色酵母を培養液中で培養して得られる培養液中の糖タ ンパク質複合体を、有効成分として含有してなるものである。  First, the emulsifier of the present invention comprises a sugar protein complex in a culture solution obtained by culturing red yeast in a culture solution as an active ingredient.

[0019] 本発明において用いられる赤色酵母としては、糖タンパク質複合体を生産できる酵 母であれば、特にその属、種については限定されることはないが、その培養が容易で あり、また栄養源として安価な材料より生育できる点から、ロドトルーラ (Rhodotorula )属、キサントフイロマイセス(Xanthophyllomyces)属、ロドスポリジゥム(Rhodospo ridium)属、キャンディダ (Candida)属、サッカロマイセス (Saccharomyces)属等 力 好ましく用いられる。  [0019] The red yeast used in the present invention is not particularly limited in terms of its genus and species as long as it is an enzyme mother capable of producing a glycoprotein complex, but its culture is easy and nutritional. Because it can grow from inexpensive materials as a source, Rhodotorula genus, Xanthophyllomyces genus, Rhodospo ridium genus, Candida genus, Saccharomyces genus etc. It is done.

[0020] さらにこれらの赤色酵母の内、乳化作用をもつ物質を大量に生産することから、 Rho dotorula mucilagmosa KUGPP— 1 、 Rhodotorula mucilaginosa NBR C0003, Xanthophyllomyces dendrorhous NBRC10129、 Rhodosporidiu m toruloides NBRC0388等が、より好ましく用いられる。  [0020] Among these red yeasts, Rho dotorula mucilagmosa KUGPP-1, Rhodotorula mucilaginosa NBR C0003, Xanthophyllomyces dendrorhous NBRC10129, Rhodosporidiu m toruloides NBRC0388 and the like are more preferably used because they produce a large amount of an emulsifying substance. It is done.

当該赤色酵母は、単独で用いても、 2種以上を併用することもできる。  The red yeast can be used alone or in combination of two or more.

なお、 Rhodotorula mucilaginosa KUGPP— 1は、南極より分離され、受託番号 FERM BP— 10500として、国際寄託日 2006年 2月 2日(原寄託日 2005年 2月 8 日の国内寄託を国際寄託へ移管)に、日本国茨城県つくば巿東 1丁目 1番地 1中央 第 6にある独立行政法人産業技術総合研究所特許生物寄託センターに寄託されて いる。  Rhodotorula mucilaginosa KUGPP-1 was separated from Antarctica and was deposited with an accession number of FERM BP-10500 on February 2, 2006 (the original deposit on February 8, 2005 was transferred to an international deposit) In addition, it is deposited at the Patent Organism Depositary, National Institute of Advanced Industrial Science and Technology, located in 1st, 1st, 1st, Tsukuba, Higashi, Ibaraki, Japan.

また、他の上記赤色酵母は、 NBRC (独立行政法人製品評価技術基盤機構バイオ テクノロジー本部生物遺伝資源部門)より入手可能である。  The other red yeast can be obtained from NBRC (Biotechnology Division, Biotechnology Headquarters, National Institute of Technology and Evaluation).

[0021] 当該赤色酵母は、培養が容易であり、大量に培養して、凝集阻害物質 (乳化成分)で ある糖タンパク質複合体を製造するのに適した性質を備えている。すなわち、当該赤 色酵母は、グルコースを唯一の炭素源とした無機塩類のみよりなる培地で良好に生 育し、その培養液中の、アセトン等によって沈殿、濃縮しうる画分 (糖タンパク質複合 体を含有する画分)に、強力な乳化活性を有する。  [0021] The red yeast is easily cultivated and has properties suitable for culturing in large quantities to produce a glycoprotein complex that is an aggregation inhibitor (emulsifying component). That is, the red yeast is a fraction (glycoprotein complex) that grows well in a medium consisting only of inorganic salts containing glucose as the only carbon source and can be precipitated and concentrated with acetone or the like in the culture medium. Have a strong emulsifying activity.

[0022] 赤色酵母の培養方法については、通常微生物の培養に用いられる培地で培養すれ ば良い。 [0022] Regarding the method for cultivating red yeast, the culture is carried out in a medium usually used for culturing microorganisms. It ’s fine.

培地に含まれる赤色酵母の成育に必要な炭素源としては、グルコースが好ましく用 いられる。その濃度は、好ましくは 0. 1〜5容量%程度、より好ましくは 0. 5〜1. 5容 量%程度である。  Glucose is preferably used as a carbon source necessary for the growth of red yeast contained in the medium. The concentration is preferably about 0.1 to 5% by volume, more preferably about 0.5 to 1.5% by volume.

この際、グルコースの代わりに、エタノール等のアルコール類や、コーン油、大豆油 等の油類を炭素源として用いることもできる。  In this case, alcohols such as ethanol and oils such as corn oil and soybean oil can be used as the carbon source instead of glucose.

[0023] また、窒素源としては、アンモ-ゥム塩が好ましく用いられ、特に pH緩衝能やリン分 の補給の点から、リン酸アンモ-ゥムが好ましい。 [0023] As the nitrogen source, an ammonium salt is preferably used, and ammonium phosphate is particularly preferable from the viewpoint of pH buffering ability and replenishment of phosphorus content.

また、培養が進行すると培地の pHが低下するため、アルカリを滴下して、好ましくは p H6〜8、より好ましくは pH6. 5〜7. 5となるように調整して、培養を行うことが好まし い。  In addition, since the pH of the medium decreases as the culture progresses, it is possible to carry out the culture by adding alkali dropwise, preferably adjusting the pH to 6 to 8, more preferably pH 6.5 to 7.5. I like it.

この際使用されるアルカリとしては、水酸化ナトリウム、水酸ィ匕カリウム、アンモニア、 ァミン化合物等、任意のものが使用できるが、細胞増殖のための窒素源を補給する 面からアンモニアが好ましく用いられる。  Any alkali such as sodium hydroxide, potassium hydroxide, ammonia, and an amine compound can be used as the alkali used in this case, but ammonia is preferably used in terms of supplying a nitrogen source for cell growth. .

[0024] また、培地には、ビタミン類等の補給のため、酵母エキスを添加しても良い。  [0024] In addition, a yeast extract may be added to the medium to supplement vitamins and the like.

また、炭素源のグルコースも細胞増殖につれて徐々に減少していくので、順次追カロ していく必要がある力 この際にアンモニアとエタノールの混合液を追加することもで きる。追加の方法としては、一定量ずつ断続的に追加する方法、連続的に追加する 方法等、あらゆる方法を採用することができる。  Also, since the glucose of the carbon source gradually decreases as the cell grows, the force that needs to be gradually added can be added at this time. A mixture of ammonia and ethanol can also be added. As an additional method, any method such as a method of intermittently adding a certain amount or a method of adding continuously can be adopted.

[0025] 培養温度としては、細胞の増殖速度の面力も通常 0〜50°Cである力 より好ましくは 25〜35°C付近である。  [0025] As the culture temperature, the surface force of the cell growth rate is usually a force of 0 to 50 ° C, more preferably around 25 to 35 ° C.

培養時間としては、特に限定されないが、好ましくは 12〜70時間、より好ましくは 24 〜48時間である。  The culture time is not particularly limited, but is preferably 12 to 70 hours, more preferably 24 to 48 hours.

培養にあたっては、撹拌培養、静置培養のいずれも採用でき、また、通気培養、密閉 培養のいずれでもよいが、微生物の増殖を早めるために、通気下で撹拌培養するこ とが好ましい。  For the culture, either agitation culture or stationary culture can be employed, and either aeration culture or closed culture may be used, but in order to accelerate the growth of microorganisms, agitation culture is preferably performed under aeration.

[0026] このようにして培養した培養液から、糖タンパク質複合体を含有する画分、さら〖こは糖 タンパク質複合体が分離 '回収される。分離 ·回収に先立って、赤色酵母菌体を遠心 分離等の操作で培養液カゝら予め除去しておくこともでき、培養液の上清を用いること ちでさる。 [0026] From the culture medium cultured in this manner, the fraction containing the glycoprotein complex, Sarakoko, is separated and recovered. Centrifugation of red yeast cells prior to separation and collection It can also be removed in advance from the culture medium by an operation such as separation, or the culture supernatant can be used.

糖タンパク質複合体の分離.回収には、セチルピリジ-ゥム塩酸、セチルトリブチル臭 酸等の 4級ァミンを利用する方法や、メタノール、エタノール、イソプロパノール等の 低級アルコールやアセトンを培養液又は培養液の上清に添加する方法等が利用で き、より高純度の製品を得るには前者の方法が、より迅速に標品を得るためには後者 の方法が好ましく用いられる。また、これら両方法を併用することもでき、その順序は どちらでも良い。  Glycoprotein complexes can be separated and recovered by methods using quaternary amines such as cetyl pyridinium hydrochloride and cetyltributyl odor, lower alcohols such as methanol, ethanol and isopropanol, and acetone. The method of adding to the supernatant can be used, and the former method is preferably used for obtaining a higher purity product, and the latter method is preferably used for obtaining a sample more rapidly. In addition, both methods can be used in combination, and either order may be used.

上記方法で分離 ·回収された糖タンパク質複合体は、公知の方法により乾燥した粉 末として、あるいは再度水に溶解して水溶液として利用される。  The glycoprotein complex separated and recovered by the above method is used as a powder dried by a known method, or again dissolved in water and used as an aqueous solution.

また、イオン交換カラム、ァフィユティーカラム等の親和性による分画、さらに限外ろ 過、ゲルろ過カラム等の分子量による分画によっても、分離 ·回収することが可能であ る。  It can also be separated and recovered by fractionation based on affinity such as ion exchange column and affinity column, and also fractionation based on molecular weight such as ultrafiltration and gel filtration column.

[0027] 本発明の乳化剤に有効成分として含まれる糖タンパク質複合体は、上記赤色酵母を 培養することにより、培養液中に赤色酵母の細胞から分泌される、高分子の糖タンパ ク質複合体である。  [0027] The glycoprotein complex contained as an active ingredient in the emulsifier of the present invention is a high-molecular sugar protein complex secreted from cells of red yeast into the culture medium by culturing the red yeast. It is.

当該糖タンパク質複合体は、培養液中に生産されるので、乳化剤としての作用が顕 著であり、また、その赤色酵母が生産した後の培養液より該糖タンパク質複合体を回 収する際の、赤色酵母菌体との分離が容易である。  Since the glycoprotein complex is produced in the culture solution, the action as an emulsifier is remarkable, and the glycoprotein complex is recovered from the culture solution after the red yeast is produced. Separation from red yeast cells is easy.

当該糖タンパク質複合体は、上記赤色酵母を培養することにより、培養液中に赤色 酵母細胞力 分泌されるものを用いることができる。また、分泌される前の細胞壁や 菌体中にとどまった状態でも利用可能である。  As the glycoprotein complex, one that is secreted by red yeast cells into the culture medium by culturing the red yeast can be used. In addition, it can be used even if it stays in the cell wall or cells before being secreted.

[0028] 当該糖タンパク質複合体とは、糖とタンパク質を有する複合体であり、糖とタンパク質 が結合した糖タンパク質、又は、その糖タンパク質に脂質等が付加した一群の物質 のことをいい、特に限定されない。なお、糖は、 1つ又は 2つ以上のオリゴ糖のことを いい、さらには特定の糖の繰り返し構造もこれに含まれる。また、タンパク質部分は、 2つ以上のアミノ酸力 なる。 [0028] The glycoprotein complex is a complex having a sugar and a protein, and refers to a glycoprotein in which a sugar and a protein are combined, or a group of substances in which lipids or the like are added to the glycoprotein. It is not limited. Sugar refers to one or more oligosaccharides, and also includes a repeating structure of a specific sugar. The protein part has two or more amino acid forces.

当該糖タンパク質複合体は、 1種でも 2種以上でも用いることができる。 [0029] 当該糖タンパク質複合体は、平均分子量として 3万以上の分子量を有することが好ま しい。つまり、糖タンパク質複合体を含有する画分の、ゲルろ過によって示される分子 量が 30, 000以上であることが好ましい。 The glycoprotein complex can be used alone or in combination of two or more. [0029] The glycoprotein complex preferably has an average molecular weight of 30,000 or more. That is, the molecular weight shown by gel filtration of the fraction containing the glycoprotein complex is preferably 30,000 or more.

当該平均分子量は、例えば、レーザー散乱計、ゲルろ過等の公知の方法により求め ることができる。本発明においては、後述の実施例で記載しているように、ゲルろ過法 により求めた。つまり、当該平均分子量は、得られた糖タンパク質複合体を、ゲルろ 過の担体(Sephacryl S— 400HR、 φ lcm X長さ 100cm)に供し、デキストランを 分子量マーカーとして、測定することができる。  The average molecular weight can be determined by a known method such as laser scatterometer or gel filtration. In the present invention, it was determined by gel filtration as described in the examples below. That is, the average molecular weight can be measured using the obtained glycoprotein complex as a gel filtration carrier (Sephacryl S-400HR, φlcm X length 100 cm) and using dextran as a molecular weight marker.

[0030] 本発明の乳化剤は、上記赤色酵母が生産する糖タンパク質複合体を有効成分として 含有するものであるが、糖タンパク質複合体を生産した赤色酵母の培養液をそのまま 、あるいは、糖タンパク質複合体を精製(=分離 ·回収)したものを用いることができる 特に乳化剤を少量で用いる場合には、精製することで乳化剤中の糖タンパク質複合 体の濃度を高めることができ、効果的である。 [0030] The emulsifier of the present invention contains the glycoprotein complex produced by the red yeast as an active ingredient, but the culture solution of the red yeast that produced the glycoprotein complex is used as it is or the glycoprotein complex. Purified (= separated / recovered) body can be used. Especially when an emulsifier is used in a small amount, the concentration of the glycoprotein complex in the emulsifier can be increased by purification.

さらには、細胞壁ゃ菌体中にとどまつている糖タンパク質複合体を利用するために、 菌体をそのまま使用したり、菌体の破砕液を利用することも可能である。  Furthermore, in order to use the glycoprotein complex that remains in the cell walls, it is possible to use the cells as they are or to use a disrupted solution of the cells.

[0031] 乳化剤中の他の成分としては、上述のように、糖タンパク質複合体以外の、赤色酵母 の培養液成分等が挙げられ、また、乳化剤としての効果をより高めるために、種々の 添加剤を用いてもよい。 [0031] As described above, the other components in the emulsifier include red yeast culture fluid components other than the glycoprotein complex, and various additives may be added to enhance the effect as an emulsifier. An agent may be used.

添加剤としては、乳化剤の剤型を保つためや、糖タンパク質複合体が分解等によりそ の効果が減じてしまうのを防ぐために、安定化剤を用いたり、実際の使用を容易とす るために、水等の液体を用いることもできる。また、添加剤として、例えば、酸化防止 剤、防腐剤、化粧用活性剤、加湿剤、スフインゴ脂質、脂溶性ポリマー等を含んでも よい。  In order to maintain the dosage form of the emulsifier and to prevent the effect of the glycoprotein complex from degrading due to degradation, etc., as a additive, a stabilizer is used or the actual use is facilitated. In addition, a liquid such as water can be used. Further, as an additive, for example, an antioxidant, an antiseptic, a cosmetic active agent, a humidifier, a sphingolipid, a fat-soluble polymer and the like may be contained.

さらに、本発明の乳化剤に加えて、既存の乳化剤を併用することもできる。  Furthermore, in addition to the emulsifier of the present invention, an existing emulsifier can be used in combination.

当該添加剤や、既存の乳化剤の添加量としては、その用途に応じて適宜決めればよ い。  What is necessary is just to determine suitably the addition amount of the said additive and the existing emulsifier according to the use.

[0032] 乳化剤の剤型としては、液状又は固体状のいずれでもよいが、脂溶性物質との接触 にお 、て乳化剤と脂溶性物質とを均一に混和するために、液状とすることが好ま ヽ [0032] The dosage form of the emulsifier may be either liquid or solid, but is in contact with a fat-soluble substance. In order to mix the emulsifier and the fat-soluble substance uniformly, it is preferable to use liquid form.

[0033] 乳化剤中の糖タンパク質複合体の含有量としては、特に限定されないが、乳化剤全 体の 0. 00001重量%〜10重量%が好ましぐ 0. 001重量%〜1重量%がより好ま しい。 [0033] The content of the glycoprotein complex in the emulsifier is not particularly limited, but 0.0001 to 10% by weight of the total emulsifier is preferable, and 0.001 to 1% by weight is more preferable. That's right.

[0034] 本発明の乳化剤の製造方法は、赤色酵母を培養液中で培養し、得られた培養液中 の糖タンパク質複合体を含有する画分を分離及び回収することを特徴とするものであ り、具体的には上述のとおりである。  [0034] The method for producing an emulsifier of the present invention is characterized in that red yeast is cultured in a culture solution, and a fraction containing the glycoprotein complex in the obtained culture solution is separated and recovered. Specifically, it is as described above.

また、糖タンパク質複合体を含有する画分を分離及び回収することにより、ゲルろ過 によって示される分子量が 30, 000以上の画分を得ることが好まし 、。  In addition, it is preferable to obtain a fraction having a molecular weight of 30,000 or more shown by gel filtration by separating and collecting a fraction containing the glycoprotein complex.

[0035] 次に、上記赤色酵母が生産する糖タンパク質複合体を含む乳化剤を用い、これと脂 溶性物質とを接触させて得られる、脂溶性物質を含有する水溶性組成物につ!ヽて説 明する。 [0035] Next, the present invention relates to a water-soluble composition containing a fat-soluble substance obtained by contacting an oil-soluble substance with an emulsifier containing a glycoprotein complex produced by the red yeast! Explain in an instant.

つまり、本発明の水溶性組成物は、上記乳化剤及び脂溶性物質を含有してなるもの である。  That is, the water-soluble composition of the present invention contains the emulsifier and the fat-soluble substance.

[0036] 本発明で用いる脂溶性物質としては、生理学的に認容されるものであれば特に限定 されないが、例えば、コェンザィム Q10等の脂溶性薬物;脂溶性ビタミン A、 D、 E、 K 、及びそれらの誘導体等のビタミン類;精油(例えば、パイン油、ライム油、ゆず油等) 、植物油(例えば、大豆油、菜種油、べに花油、コーン油、ごま油、綿実油、ォリーブ 油、パーム油、ひまわり油等)、動物油 (例えば、牛脂、ラード等)等の油脂;脂溶性色 素(例えば、アナトー、ゥコン、ベニコウジ、クロロフィル等);香料 (例えば、オレンジォ ィル等);カロチノイド(例えば、カンタキサンチン、ァスタキサンチン、ゼアキサンチン 、リコピン、アポカロチナーノレ、 β一力ロチン等)等が挙げられる。  [0036] The fat-soluble substance used in the present invention is not particularly limited as long as it is physiologically acceptable. For example, fat-soluble drugs such as Coenzyme Q10; fat-soluble vitamins A, D, E, K, and Vitamins such as derivatives thereof; essential oil (for example, pine oil, lime oil, yuzu oil), vegetable oil (for example, soybean oil, rapeseed oil, bean flower oil, corn oil, sesame oil, cottonseed oil, olive oil, palm oil, sunflower oil Oils such as beef tallow, lard, etc .; fat-soluble pigments (eg, Anato, Tucon, Benikouji, chlorophyll, etc.); perfumes (eg, orange oil); carotenoids (eg, canthaxanthin Astaxanthin, zeaxanthin, lycopene, apocarotinanol, β-strength rotin, etc.).

当該脂溶性物質は、単独で用いても、 2種以上を併用することもできる。  These fat-soluble substances can be used alone or in combination of two or more.

[0037] 本発明の水溶性組成物には、上述の乳化剤で例示した添加剤をはじめ、顔料、調 味料、抗菌剤等の種々の成分を含有させることができ、食品、化粧品、入浴剤等を含 む工業品としての様々な性能を付与することができる。  [0037] The water-soluble composition of the present invention can contain various components such as pigments, seasonings, antibacterial agents, and the like, in addition to the additives exemplified in the above-mentioned emulsifiers, foods, cosmetics, bathing agents. Various performances as industrial products including the above can be imparted.

また、当該水溶性組成物には、水;エタノール等のアルコール類等の溶媒を添加す ることもでき、好まし 、。 In addition, water; a solvent such as alcohol such as ethanol is added to the water-soluble composition. Can also be preferred.

[0038] 当該水溶性組成物中の糖タンパク質複合体の含有量としては、特に限定されないが 、水溶性組成物全体の 0. 00001重量%〜 10重量%が好ましぐ 0. 001重量%〜1 重量%がより好ましい。  [0038] The content of the glycoprotein complex in the water-soluble composition is not particularly limited, but 0.0001% to 10% by weight of the whole water-soluble composition is preferable. 0.001% to 1% by weight is more preferred.

脂溶性物質の含有量としては、特に限定されないが、水溶性組成物全体の 0. 0000 1重量%〜30重量%が好ましぐ 0. 001重量%〜10重量%がより好ましい。  The content of the fat-soluble substance is not particularly limited, but 0.001 to 30% by weight of the entire water-soluble composition is preferable, and 0.001 to 10% by weight is more preferable.

[0039] 本発明の水溶性組成物の製造方法は、上記乳化剤及び脂溶性物質を混合すること を特徴とするものである。  [0039] The method for producing a water-soluble composition of the present invention is characterized by mixing the emulsifier and the fat-soluble substance.

[0040] 当該水溶性組成物の製造方法においては、乳化剤と脂溶性物質とを接触させ、両 者を混和する。混和の方法としては、振とう、撹拌等、両者が十分に接触できるもの であれば特に限定されないが、脂溶性物質等の粘性が比較的高いものを速やかに かつ十分に混和するために、攪拌することが好ましぐさらに撹拌に際しては、激しく 撹拌することが好ましい。このような乳化剤と脂溶性物質との混和方法としては、ヮー リングブレンダーゃジューサーを用いる方法、マントンーゴーリンホモジナイザーを用 いる方法、超音波を利用する方法等、公知の方法が利用できる。  [0040] In the method for producing the water-soluble composition, an emulsifier and a fat-soluble substance are brought into contact with each other, and both are mixed. The mixing method is not particularly limited as long as both can be sufficiently brought into contact with each other, such as shaking and stirring. However, in order to quickly and sufficiently mix a material having a relatively high viscosity such as a fat-soluble substance, stirring is performed. In addition, it is preferable to vigorously stir the mixture. As a method for mixing such an emulsifier and a fat-soluble substance, known methods such as a method using a milling blender and a juicer, a method using a Manton-Gorin homogenizer, and a method using ultrasonic waves can be used.

[0041] また、乳化剤と脂溶性物質とを接触させ、さらに両者を混和させる条件において、処 理温度、処理時間等も考慮する必要があるが、用いる脂溶性物質の種類や、得られ る脂溶性物質を含有する水溶性組成物の用途に応じて、適宜適した条件にて行うこ とでよい。 [0041] In addition, it is necessary to consider the processing temperature, processing time, etc. under the conditions in which the emulsifier and the fat-soluble substance are brought into contact with each other and further mixed, but the type of the fat-soluble substance to be used and the fat obtained Depending on the use of the water-soluble composition containing a soluble substance, it may be carried out under appropriate conditions.

例えば、混和中に熱が発生することがあるため、耐熱性の余りない材料を用いる場合 には、高温とならないように注意して混和する必要がある。具体的には、食品等への 適用や、塗料等のように揮発性を有する溶媒等が含まれる場合への適用には、前者 につ ヽては微生物の繁殖がな 、ように、後者につ!ヽては溶媒が揮発してしまわな!/ヽ ように、短時間で実施する必要がある。  For example, heat may be generated during mixing, so when using a material that does not have enough heat resistance, it is necessary to mix carefully so as not to reach a high temperature. Specifically, for the application to foods, etc., and the case where volatile solvents such as paints are included, the latter does not cause microbial growth. It should be done in a short time so that the solvent will volatilize!

[0042] また、脂溶性物質に乳化剤を加える場合、両者を一度に加えた後に混和してもよい 1S 両者を少量ずっ徐々にカ卩えて混和する、また、片方をもう一方へ徐々に加えて 混和する等、あらゆる形態を採用できる。 [0042] In addition, when adding an emulsifier to a fat-soluble substance, both may be mixed after adding them at the same time 1S Add both of them gradually and mix them, or gradually add one to the other. Any form such as mixing can be adopted.

発明の効果 [0043] 本発明により、安全性の高い、単独で高い乳化性と乳化安定性を示す新規な乳化剤 を得ることができ、また、当該乳化剤を用いることにより、安定に乳化された、脂溶性 物質を含有する水溶性組成物を得ることができ、産業上での貢献は非常に大きいも のである。 The invention's effect [0043] According to the present invention, a novel emulsifier having high safety and high emulsifiability and emulsification stability can be obtained, and a fat-soluble substance stably emulsified by using the emulsifier. It is possible to obtain a water-soluble composition containing benzene, and the contribution to the industry is very large.

発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION

[0044] 以下に、実施例を用いて本発明をより詳細に説明するが、本発明はこれらに限定さ れるものではない。  [0044] Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited thereto.

[0045] 実施例 1 :酵母培養液由来の粗乳化剤の調整  Example 1: Preparation of crude emulsifier derived from yeast culture solution

10mlの YM培地(酵母エキス 0. 03g、モル卜エキス 0. 03g、ぺプ卜ン 0. 05g、ダルコ ース 0. lg、 pH6. 0)を調製し、オートクレープを用いて滅菌操作を行った。これに、 独立行政法人産業技術総合研究所特許生物寄託センターに寄託されている赤色酵 母 Rhodotorula mucilaginosa KUGPP— 1 (FERM BP— 10500)を接種し、 30°Cでー晚培養し、これを前培養液とした。この前培養液を 500mlの同培地に接種 し、 30°Cで 48時間培養した後、遠心により菌体を除いた約 500mlの上清を回収した 。この上清をカットオフ値 MW100, 000の限外ろ過膜を用いて約 30mほで濃縮を 行った。その後、緩衝液 A[20mMリン酸カリウム緩衝液 (pH7. 0) ]に対して透析を 実施し、これを粗乳化剤(サンプル A)とした。  Prepare 10 ml of YM medium (0.03 g yeast extract, 0.03 g molasses extract, 0.05 g peptone, 0 lg darcose, pH 6.0) and sterilize using autoclave. It was. This was inoculated with the red fermentation mother Rhodotorula mucilaginosa KUGPP-1 (FERM BP-10500) deposited at the Patent Organism Depositary of the National Institute of Advanced Industrial Science and Technology. A culture solution was obtained. This preculture was inoculated into 500 ml of the same medium and cultured at 30 ° C. for 48 hours, and then about 500 ml of supernatant from which the cells had been removed was collected by centrifugation. The supernatant was concentrated at about 30 m using an ultrafiltration membrane with a cutoff value of MW 100,000. Thereafter, dialysis was performed against buffer A [20 mM potassium phosphate buffer (pH 7.0)], and this was used as a crude emulsifier (sample A).

なお、本乳化剤の活性は、サンプル 100 1を 1. 8mlの緩衝液 Aに添カ卩し、そこへ、 ジメチルスルホキシドに 200 μ gZmlになるように溶解させたァスタキサンチン(和光 純薬社製)を 100 1加え、よく混合し、約 26°Cで 15分間静置後に凝集しないことを 指標にした。つまり、約 26°Cで 15分間静置後に凝集しない場合に、乳化活性がある ものとした。  The activity of this emulsifier was determined by adding sample 100 1 to 1.8 ml of Buffer A and dissolving it in dimethyl sulfoxide to 200 μg Zml (Wax Junyaku Co., Ltd.). ) Was added and mixed well, and the index was that it did not aggregate after standing at about 26 ° C for 15 minutes. In other words, if it does not aggregate after standing at about 26 ° C for 15 minutes, it has emulsification activity.

[0046] このサンプル Aに約 4倍量のアセトンを加え、遠心により沈殿物を回収した。この沈殿 物を約 5mlの緩衝液 B[20mMトリス塩酸緩衝液 (pH8. 0) ]に懸濁、透析後、予め 緩衝液 Bで平衡化した陰イオン交換榭脂である DEAE—TOYOPEARL650M (東 ソ一社製)を充填したカラム( φ 1. 6cm X 10cm)に負荷し、 0から 1. 0Mへの塩化ナ トリウムの直線濃度勾配法 (総溶出量 360ml)で溶出させ、塩ィ匕ナトリウム濃度が 300 mMから 350mMの間に溶出してくる約 20mlの乳化活性画分を回収した。この画分 を、限外ろ過膜により約 1. 5mlに濃縮し、これをサンプル Bとした。 [0046] About four times the amount of acetone was added to Sample A, and the precipitate was collected by centrifugation. This precipitate is suspended in about 5 ml of buffer B [20 mM Tris-HCl buffer (pH 8.0)], dialyzed, and then anion-exchanged resin DEAE—TOYOPEARL650M (Tosoh) pre-equilibrated with buffer B. Load a column (φ1.6 cm x 10 cm) packed with a single company, and elute with a linear concentration gradient of sodium chloride from 0 to 1.0 M (total elution volume 360 ml) to obtain a sodium chloride concentration. About 20 ml of the emulsifying active fraction eluted between 300 mM and 350 mM. This fraction Was concentrated to about 1.5 ml with an ultrafiltration membrane, and this was used as sample B.

これを、緩衝液 C[50mMリン酸カリウム緩衝液 (pH7. 0) ]で平衡ィ匕した Sephacryl S— 400HR (アマシャム社製)を充填したカラム( φ 1 cm X 100cm)を用いたゲル ろ過に供し、約 5mlの活性画分 (乳化作用物質)を獲得し、これをサンプル Cとした( ゲルろ過時のピークからほぼ単一精製物であった)。  This was subjected to gel filtration using a column (φ 1 cm x 100 cm) packed with Sephacryl S-400HR (Amersham) equilibrated with buffer C [50 mM potassium phosphate buffer (pH 7.0)]. Then, about 5 ml of an active fraction (emulsifying agent) was obtained, and this was designated as sample C (which was almost a single purified product from the peak during gel filtration).

サンプル Cを用いて、フエノール硫酸法を用いて糖量(グルコース換算)を、 BCAキッ ト (PIERCE社製)を用いてタンパク質量 (BSA換算)を求めたところ、総糖量は 2. 6 mg、総タンパク質量は 0. 3mgであった。これから、本乳化剤は糖とタンパク質が約 9 対 1の割合で含まれるということが判明した。  Using sample C, the amount of sugar (converted to glucose) was determined using the phenol-sulfuric acid method, and the amount of protein (converted to BSA) was determined using the BCA kit (PIERCE). The total amount of sugar was 2.6 mg. The total protein amount was 0.3 mg. From this, it was found that this emulsifier contains sugar and protein in a ratio of about 9: 1.

[0047] 実施例 2 :乳化作用評価 [0047] Example 2: Evaluation of emulsifying action

実施例 1で調製したサンプル Aの 100 1を、 1. 8mlの緩衝液 A [ 20mMリン酸力リゥ ム緩衝液(PH7. 0) ]に添加し、そこへ、ジメチルスルホキシドに 200 gZmlになる ように溶解させたァスタキサンチン (和光純薬社製)を 100 1加え、よく混合した。ま たコントロールとして、 Saccharomyces cerevisiae NBRC223の培養液を実施 例 1に従って調製したものを使用した。  Add 100 1 of sample A prepared in Example 1 to 1.8 ml of Buffer A [20 mM phosphate buffer (PH 7.0)], and add 200 gZml in dimethyl sulfoxide. 1001 of wastaxanthin (manufactured by Wako Pure Chemical Industries, Ltd.) dissolved in 1 was added and mixed well. As a control, a culture solution of Saccharomyces cerevisiae NBRC223 prepared according to Example 1 was used.

25°Cで 24時間まで静置して観察したところ、コントロールにおいては、約 1時間後か らァスタキサンチンの凝集物が析出し始め、 24時間後には全てが沈殿してしまって いた。ところが、サンプル Aを添カ卩したものでは、 24時間経過した時点においても、 全く凝集が見られな力つた。また、このサンプル Aとァスタキサンチンの混合物を 100 °Cで 1時間処理しても、凝集物は析出しな力つた。さらに、これらサンプル Aとァスタキ サンチンとの混合物を 1週間室温(25°C)で放置しても、凝集物の析出はみられなか つた o  When observed by standing at 25 ° C. for up to 24 hours, in the control, agastaxanthin aggregates started to precipitate after about 1 hour, and after 24 hours, all had precipitated. However, when sample A was added, there was no agglomeration even after 24 hours. Further, even when this mixture of sample A and wastaxanthin was treated at 100 ° C. for 1 hour, the aggregates did not precipitate. Furthermore, even when the mixture of sample A and ataxanthin was allowed to stand at room temperature (25 ° C) for 1 week, no aggregates were observed o

[0048] 実施例 3 :乳化作用物質の精製  [0048] Example 3: Purification of emulsifying agent

実施例 1で調製したサンプル Aを、予め緩衝液 B[20mMトリス塩酸緩衝液 (pH8. 0) ]で平衡化した陰イオン交換榭脂である DEAE—TOYOPEARL650M (東ソ一社 製) 30mlを充填したカラム( φ 1. 6cm X 10cm)に負荷し、 0力ら 1. 0Mへの塩化ナ トリウムの直線濃度勾配法 (総溶出量 760ml)で溶出させ、塩ィ匕ナトリウム濃度が 300 mMから 400mMの間に溶出してくる約 20mlの乳化活性画分を回収した。この画分 を、遠心限外濾過膜セントリブレップ— 10 (アミコン社製)を用いて約 2mlに濃縮した 。これを、緩衝液 C[50mMリン酸カリウム緩衝液 (pH7. 0) ]で平衡ィ匕した Superose 12 (フアルマシア社製)を充填したカラム(φ 1. 6cmX 100cm)を用いたゲルろ過に 供し、約 2mlの活性画分 (乳化作用物質)を得た。 Sample A prepared in Example 1 is filled with 30 ml of DEAE—TOYOPEARL650M (manufactured by Tosohichi Co., Ltd.), which is an anion exchange resin that has been equilibrated in advance with buffer B [20 mM Tris-HCl buffer (pH 8.0)]. Column (φ1.6 cm x 10 cm), eluting with sodium chloride linear gradient method (total elution volume 760 ml) to 1.0 M and 0 force, and sodium chloride concentration from 300 mM to 400 mM About 20 ml of the emulsifying active fraction eluted during the period was recovered. This fraction Was concentrated to about 2 ml using a centrifugal ultrafiltration membrane Centrivep-10 (Amicon). This was subjected to gel filtration using a column (φ1.6 cm × 100 cm) packed with Superose 12 (manufactured by Pharmacia) equilibrated with buffer C [50 mM potassium phosphate buffer (pH 7.0)] About 2 ml of active fraction (emulsifying agent) was obtained.

次いで、 ProteinaseK (SIGMA社製)を 200UZmlとなるよう調製し、活性画分と 1 : Next, ProteinaseK (manufactured by SIGMA) was prepared to 200 UZml.

9 (最終 ProteinaseK濃度 20UZml)で混合し、 25°Cで 2時間保持した。 9 (final Proteinase K concentration 20UZml) and kept at 25 ° C for 2 hours.

このサンプルを用いて、実施例 2と同様にして乳化作用を評価したところ、乳化作用 が見られなくなった。また、この精製過程での画分の活性の強弱は、糖の吸収の強 弱と一致していた。これらのことから、乳化作用物質は糖タンパク質であると考えられ た。  When this sample was used to evaluate the emulsifying action in the same manner as in Example 2, the emulsifying action was not observed. In addition, the activity of the fraction during this purification process was consistent with the strength of sugar absorption. From these facts, the emulsifying agent was considered to be a glycoprotein.

[0049] 実施例 4 :乳化作用物質の分子量の測定  [0049] Example 4: Measurement of molecular weight of emulsifying agent

実施例 1で精製したサンプル Cの 1. 5mlを、ゲルろ過の担体(Sephacryl S— 400 HR、 φ 1cm X長さ 100cm)に供し、デキストランを分子量マーカーとして分子量の 測定を行った。この結果、本乳化作用物質は、分子量約 730, 000であることが推測 された。  1.5 ml of the sample C purified in Example 1 was applied to a gel filtration carrier (Sephacryl S-400 HR, φ 1 cm X length 100 cm), and molecular weight was measured using dextran as a molecular weight marker. As a result, it was estimated that this emulsifying agent had a molecular weight of about 730,000.

[0050] 実施例 5 : β—カロチン、ビタミン (Α、 Ε、 Κ)、コェンザィム Q10の乳化作用  [0050] Example 5: Emulsifying action of β-carotene, vitamins (Α, Ε, Κ) and Coenzyme Q10

実施例 3で調製した乳化作用物質 100 1を、 0. 9mlの 10mMリン酸カリウム緩衝液 (pH7. 0)に添加したものを、 10mgの カロチン (ナカライテスタ社製)、ビタミン A (ナカライテスタ社製)、ビタミン E (ナカライテスタ社製)、ビタミン K1 (ナカライテスタ社 製)、コェンザィム Q10それぞれに加え、よく混合した。またコントロールとして、 Sacc haromyces cerevisiae NBRC223の培養液を実施例 1に従って調製したものを 使用した。  Emulsifying agent 100 1 prepared in Example 3 was added to 0.9 ml of 10 mM potassium phosphate buffer (pH 7.0), 10 mg of carotene (manufactured by Nacalai Testa), vitamin A (Nacalai Tester) ), Vitamin E (manufactured by Nacalai Testa), vitamin K1 (manufactured by Nacalai Testa), and Coenzyme Q10, and mixed well. As a control, a culture solution of Sacc haromyces cerevisiae NBRC223 prepared according to Example 1 was used.

25°Cで 24時間まで静置して観察したところ、コントロールにおいては、添加直後から 各サンプルの凝集物が析出し始め、 1時間後には全てが沈殿してしまっていた。とこ ろ力 上記粗乳化剤を添加したものでは、 24時間経過した時点においても、全く凝 集が見られなカゝつた。  When observed by standing at 25 ° C for up to 24 hours, in the control, aggregates of each sample started to precipitate immediately after the addition, and after 1 hour, all of them had precipitated. Coarse force When the above crude emulsifier was added, no aggregation was observed even after 24 hours.

[0051] 実施例 6:他の赤色酵母培養液の乳化作用 [0051] Example 6: Emulsification of other red yeast cultures

試験管に入れた 100mlの YM培地に、赤色酵母である Rhodotorula mucilagino sa NBRC0003, Xanthophyllomyces dendrorhous NBRC10129、 Rhodos poridium toruloides NBRC0388をそれぞれ接種し、 30°C、 120rpmで 48時間 培養し、その培養液について 10, 000 X g、 20分間の遠心分離を行い、菌体を除い た約 100mlの上清を回収した。この画分を、遠心限外濾過膜セントリブレップ— 10 ( アミコン社製)を用いて約 10mlに濃縮し、これを粗乳化剤とした。 Rhodotorula mucilagino, a red yeast, in 100 ml of YM medium in a test tube sa NBRC0003, Xanthophyllomyces dendrorhous NBRC10129, Rhodos poridium toruloides NBRC0388, respectively, and cultured at 30 ° C, 120rpm for 48 hours. About 100 ml of supernatant was collected. This fraction was concentrated to about 10 ml using a centrifugal ultrafiltration membrane Centrivep-10 (Amicon), and this was used as a crude emulsifier.

[0052] 実施例 2と同様にして、ァスタキサンチンに対する乳化作用、及び、実施例 5と同様 にして、 j8—カロチン、ビタミン (A、 E、 K)、コェンザィム Q 10それぞれに対する乳化 作用を評価したところ、何れの株においても乳化作用が見られた。 [0052] In the same manner as in Example 2, the emulsifying effect on wastaxanthin and in the same manner as in Example 5, the emulsifying effect on j8-carotene, vitamins (A, E, K), and Coenzyme Q10 were evaluated. As a result, an emulsifying action was observed in all strains.

また、これら赤色酵母由来の粗乳化剤を、遠心限外濾過膜セントリブレップ— 30 (ァ ミコン社製)を用いて濾過したところ、そのろ液 (つまり分子量 30, 000未満)には乳 化作用がな力つたことから、乳化作用を示す物質は 30, 000以上であることが推測さ れた。  Moreover, when the crude emulsifier derived from red yeast was filtered using a centrifugal ultrafiltration membrane Centribrep-30 (manufactured by Amicon), the filtrate (that is, the molecular weight of less than 30,000) was emulsified. Therefore, it was estimated that more than 30,000 substances have an emulsifying effect.

[0053] 実施例 7 : pH安定性  [0053] Example 7: pH stability

実施例 1で調製したサンプル Bを、 pH5と 6の 50mM酢酸ナトリウム緩衝液、 pH6、 7 及び 8の 50mMリン酸カリウム緩衝液、 pH8と 9の 50mMトリス緩衝液、 pH9と 10の 5 OmM炭酸ナトリウム緩衝液で透析を行った後、サンプル Bの 100 1を最終濃度 10 /z gZml〖こなるよう〖こ、 1. 8mlのそれぞれの pH緩衝液に添カロし、そこへ、ジメチルス ルホキシドに 200 μ gZmlになるように溶解させたァスタキサンチン (和光純薬社製) を 100 /z l加え、よく混合した。混合直後の 440nmにおける吸光度の絶対値 (I)と、 室温 (約 26°C)で 15分間静置後の 440nmにおける吸光度の絶対値 (Π)を測定し、 ( I) - (Π)を算出し(ΔΑ )、それを図 1に示した。なお、ァスタキサンチンの凝集が見  Sample B prepared in Example 1 was mixed with 50 mM sodium acetate buffer at pH 5 and 6, 50 mM potassium phosphate buffer at pH 6, 7 and 8, 50 mM Tris buffer at pH 8 and 9, 5 OmM sodium carbonate at pH 9 and 10. After dialyzing with buffer solution, add 100 1 of sample B to a final concentration of 10 / z gZml, 1. Carry it with 8 ml of each pH buffer solution, and add 200 μl to dimethylsulfoxide. Axaxanthin (manufactured by Wako Pure Chemical Industries) dissolved in gZml was added at 100 / zl and mixed well. Measure the absolute value (I) of absorbance at 440nm immediately after mixing and the absolute value (に お け る) of absorbance at 440nm after standing at room temperature (about 26 ° C) for 15 minutes to calculate (I)-(Π) (ΔΑ), which is shown in FIG. In addition, astaxanthin aggregation was observed.

440  440

られたものは、ァスタキサンチンの最大吸収波長である 440nmの吸光度の絶対値が 低下する。上記 (I)一(Π)が、 0〜0. 1の範囲内であれば乳化が安定であると判定し た。  As a result, the absolute value of absorbance at 440 nm, which is the maximum absorption wavelength of wastaxanthin, decreases. If the above (I) one (Π) was within the range of 0 to 0.1, it was determined that the emulsification was stable.

その結果、本発明の乳化剤は幅広い pHで効果を発揮することが判明した。  As a result, it has been found that the emulsifier of the present invention is effective over a wide pH range.

[0054] 実施例 8:乳化作用の強さにつ 、て (ァスタキサンチンを用いて) [0054] Example 8: Strength of emulsifying action (using aastaxanthin)

実施例 1で調製したサンプル Cを最終濃度 (糖量換算)で 1、 5、 10 gZmlになるよ うに調製したそれぞれ 100 1を、 1. 8mlの緩衝液 Aに添カ卩し、そこへ、ジメチルスル ホキシドに lmg/mlになるように溶解させたァスタキサンチン (和光純薬社製)を 100 1力!]え、よく混合した。同時に市販のバイオサーファタタントであるサーファタチン Na (和光純薬社製)を最終濃度 1、 5、 10 gZmlになるように添加したものも実施した。 26°Cで 24時間静置後の 440nmにおける吸光度の絶対値を測定した結果を表 1に 示した。 Add 100 C of Sample C prepared in Example 1 to a final concentration (sugar equivalent) of 1, 5, and 10 gZml, respectively, and add it to 1.8 ml of Buffer A. Dimethyl sul 100 1 power of axaxanthin (manufactured by Wako Pure Chemical Industries, Ltd.) dissolved in loxide / ml in hydroxide! ] Well mixed. At the same time, a commercially available biosurfactant, Surfatatin Na (manufactured by Wako Pure Chemical Industries, Ltd.) was added to a final concentration of 1, 5 and 10 gZml. Table 1 shows the results of measuring the absolute value of absorbance at 440 nm after standing at 26 ° C for 24 hours.

その結果、サンプル Cの乳化剤は、低濃度でもァスタキサンチンを安定に乳化したの に対し、サーファタチン Naは、低濃度の場合にァスタキサンチンが凝集した (ァスタキ サンチンの吸光度の絶対値が低下)。つまり、本発明の乳化剤は、ァスタキサンチン に対し、サーファタチン Naよりも高い乳化作用を示すことが明ら力となった。  As a result, the emulsifier of sample C stably emulsified the astaxanthin even at a low concentration, whereas surfatatin Na aggregated the atastaxanthin at a low concentration (the absolute value of the absorbance of astaxanthin decreased) . That is, it became clear that the emulsifier of the present invention exhibits a higher emulsifying action than is surfatatin Na against wastaxanthin.

[0055] [表 1] [0055] [Table 1]

Figure imgf000017_0001
Figure imgf000017_0001

[0056] 実施例 9 :色素退色を押さえる効果  [0056] Example 9: Effect of suppressing dye fading

実施例 1で調製したサンプル Cの 100 1を、 1. 8mlの緩衝液 A [20mMリン酸力リウ ム緩衝液 (pH7. 0) ]に加え (糖換算で最終濃度 10 μ g/ml)、これに、ジメチルスル ホキシドに lmg/mlになるように溶解させたァスタキサンチンを 100 1加え、よく混 合した。また、市販のバイオサーファタタントであるサーファタチン Na (和光純薬社製 )も同じ濃度になるように添加し、それぞれを 26°Cで 1ヶ月保存した後、これら溶液の 200nm〜700nmでのスペクトル測定(U— 2000A、 日立製作所社製)を行った結 果を図 2に示した。なお、この際、サンプル Cゃサーファタチン Naの代わりに 100 1 の緩衝液 Aをカ卩えたものをコントロールとし、ァスタキサンチン添カ卩直後のスペクトル 測定を行ない、これを比較対照とした。データ 1はコントロール (添加直後)のもの、デ ータ 2はサンプル C (26°Cで 1ヶ月保存後)のもの、データ 3はサーファタチン Na (26 °Cで 1ヶ月保存後)のものを示す。  Add 100 1 of sample C prepared in Example 1 to 1. 8 ml of buffer A [20 mM phosphate buffer (pH 7.0)] (final concentration in terms of sugar: 10 μg / ml) To this, 100 1 wasastaxanthin dissolved in dimethyl sulfoxide so as to be 1 mg / ml was added and mixed well. In addition, Surfactatin Na (manufactured by Wako Pure Chemical Industries, Ltd.), a commercially available biosurfactant, was added to the same concentration, and each was stored at 26 ° C for 1 month, and then the spectrum of these solutions at 200 nm to 700 nm was The results of measurement (U-2000A, manufactured by Hitachi, Ltd.) are shown in FIG. At this time, sample C containing 100 1 of buffer A instead of surfatatin Na was used as a control, and the spectrum was measured immediately after the addition of astaxanthin and used as a comparative control. Data 1 is for control (immediately after addition), data 2 is for sample C (after storage at 26 ° C for 1 month), and data 3 is for surfatatin Na (after storage at 26 ° C for 1 month) .

その結果、本発明の乳ィ匕剤の存在下では、ァスタキサンチンの吸収スペクトルに変 化はなく安定である力 サーファタチン Naの存在下では、ァスタキサンチンが凝集し たため、吸収スペクトルに変化が生じ、経時的に色調が変化した。つまり、本発明の 乳化剤は、 1力月放置した後でも添加直後の色調を保持していることが判明した。 As a result, in the presence of the whey agent of the present invention, the absorption spectrum of istaxanthin is unchanged and stable. In the presence of surfatatin Na, the absorption spectrum is changed because astaxanthin aggregates. The color tone changed over time. That is, the present invention It was found that the emulsifier retained the color immediately after addition even after being left for 1 month.

[0057] 実施例 10 :糖組成分析 Example 10: Sugar composition analysis

実施例 1で調製したサンプル Cに、最終濃度 2Nになるように濃硫酸を添加し、 100 °Cで 4時間処理した。水酸ィ匕ナトリウムで中和した後、 20 gZml (グルコース換算の 糖濃度)のサンプルを 100 1用い、糖分析用カラム (TSKgel Suger AXG、東ソ 一社製)で分析を行った。その結果を図 3に示した。  Concentrated sulfuric acid was added to Sample C prepared in Example 1 to a final concentration of 2N, and treated at 100 ° C. for 4 hours. After neutralization with sodium hydroxide sodium hydroxide, a sample of 20 gZml (glucose equivalent sugar concentration) was used for analysis with a sugar analysis column (TSKgel Suger AXG, manufactured by Tosoh Corporation). The results are shown in Fig. 3.

同時に、単糖の標準品と比較したところ、これら 3つのピークはリテンションタイムの早 いものから順にマンノース、ガラクトース、グルコースのピークと一致した。  At the same time, when compared with the monosaccharide standard, these three peaks coincided with the peaks of mannose, galactose, and glucose in order from the one with the highest retention time.

[0058] 実施例 11 :粒子径  Example 11: Particle diameter

1. 8mlの緩衝液 Aに、ジメチルスルホキシドに 12. 5 gZml〖こなるよう〖こ溶解させ たァスタキサンチン溶液を 100 1添加し、実施例 1で調製したサンプル Cを最終濃 度 Α: 0. 125 ^ 8/πι1, Β: 0. 25 g/mlになるように 100 1添カロし、よく混禾口した。 なお、サーファタチン Na (和光純薬社製)も同濃度で実施した。 26°Cで 24時間保存 した後、動的光散乱式粒径分布装置 (LB— 550、堀場製作所社製)を用いて、溶液 中のァスタキサンチンの粒径を測定し、その平均粒径 (nm)の結果を表 2に示す。 この結果から、本発明の乳化剤を用いると、市販のバイオサーファタタントを用いるよ りも、脂溶性物質であるァスタキサンチンの粒径がより小さいものが形成されることが 判明した。 1. Add 100 1 of the astaxanthin solution dissolved in 12.5 gZml of dimethyl sulfoxide to 8 ml of buffer A, and add the sample C prepared in Example 1 to the final concentration Α: 0 125 ^ 8 / πι1, Β: 100 1 added to make 0.25 g / ml and mixed well. Surfactin Na (manufactured by Wako Pure Chemical Industries, Ltd.) was also carried out at the same concentration. After storage for 24 hours at 26 ° C, the particle size of astaxanthin in the solution was measured using a dynamic light scattering particle size distribution device (LB-550, manufactured by HORIBA, Ltd.), and the average particle size was measured. The results for (nm) are shown in Table 2. From this result, it was found that when the emulsifier of the present invention was used, a fat-soluble substance, axaxanthin having a smaller particle size, was formed as compared with using a commercially available biosurfactant.

[0059] [表 2]  [0059] [Table 2]

Figure imgf000018_0001
Figure imgf000018_0001

産業上の利用可能性  Industrial applicability

[0060] 本発明により、安全性の高い、単独で高い乳化性と乳化安定性を示す新規な乳化剤 を得ることができ、また、当該乳化剤を用いることにより、安定に乳化された、脂溶性 物質を含有する水溶性組成物を得ることができ、産業上での貢献は非常に大きいも のである。 図面の簡単な説明 [0060] According to the present invention, it is possible to obtain a novel emulsifier having high safety and exhibiting high emulsifiability and emulsification stability alone, and by using the emulsifier, a fat-soluble substance stably emulsified. It is possible to obtain a water-soluble composition containing benzene, and the contribution to the industry is very large. Brief Description of Drawings

[図 1]乳化剤の pH安定性を示すグラフである。 FIG. 1 is a graph showing the pH stability of an emulsifier.

[図 2]色素退色を押さえる効果を示すグラフである。  FIG. 2 is a graph showing the effect of suppressing dye fading.

[図 3]糖組成分析のグラフである。 FIG. 3 is a graph of sugar composition analysis.

Claims

請求の範囲 The scope of the claims [I] 赤色酵母を培養液中で培養して得られる培養液中の糖タンパク質複合体を、有効成 分として含有してなる乳化剤。  [I] An emulsifier comprising, as an active ingredient, a glycoprotein complex in a culture solution obtained by culturing red yeast in a culture solution. [2」 該赤色酵母力 Rhodotorula属、 Xanthophyllomyces属及び Rhodosporidium 属から選ばれる少なくとも 1種であることを特徴とする請求項 1記載の乳化剤。  [2] The emulsifier according to claim 1, wherein the emulsifier is at least one selected from the genera Rhodotorula, Xanthophyllomyces and Rhodosporidium. [3] 該赤色酵母力 Rhodotorula mucilaginosa KUGPP— 1、 Rhodotorula muc ilaginosa NBRC0003, Xanthophyllomyces dendrorhous NBRC10129、 及び、 Rhodosporidium toruloides NBRC0388から選ばれる少なくとも 1種であ ることを特徴とする請求項 1又は 2記載の乳化剤。  [3] The emulsifier according to claim 1 or 2, wherein the emulsifier is at least one selected from the red yeast power Rhodotorula mucilaginosa KUGPP-1, Rhodotorula mucilaginosa NBRC0003, Xanthophyllomyces dendrorhous NBRC10129, and Rhodosporidium toruloides NBRC0388. [4] 該糖タンパク質複合体の、ゲルろ過によって示される分子量が 30, 000以上である 請求項 1〜3のいずれかに記載の乳化剤。  [4] The emulsifier according to any one of claims 1 to 3, wherein the glycoprotein complex has a molecular weight of 30,000 or more as indicated by gel filtration. [5] 請求項 1〜4のいずれかに記載の乳化剤及び脂溶性物質を含有してなる水溶性組 成物。  [5] A water-soluble composition comprising the emulsifier according to any one of claims 1 to 4 and a fat-soluble substance. [6] 該脂溶性物質が、脂溶性薬物、ビタミン類、油脂、脂溶性色素、香料及びカロチノィ ドから選ばれる 1種以上である、請求項 5記載の水溶性組成物。  6. The water-soluble composition according to claim 5, wherein the fat-soluble substance is one or more selected from fat-soluble drugs, vitamins, fats and oils, fat-soluble pigments, fragrances and carotenoids. [7] 該脂溶性薬物がコェンザィム Q10であり、該ビタミン類がビタミン A、 D、 E、 K、及び それらの誘導体力 選ばれる 1種以上であり、該油脂が精油、植物油及び動物油か ら選ばれる 1種以上であり、該カロチノイドがカンタキサンチン、ァスタキサンチン、ゼ アキサンチン、リコピン、アポカロチナール及び j8—力ロチン力 選ばれる 1種以上で ある、請求項 6記載の水溶性組成物。  [7] The fat-soluble drug is Coenzyme Q10, the vitamins are one or more selected from vitamins A, D, E, K, and derivatives thereof, and the fat is selected from essential oils, vegetable oils and animal oils 7. The water-soluble composition according to claim 6, wherein the carotenoid is at least one selected from canthaxanthin, austaxanthin, zeaxanthin, lycopene, apocarotinal and j8-power rotin power. [8] 赤色酵母を培養液中で培養し、得られた培養液中の糖タンパク質複合体を含有する 画分を分離及び回収することを特徴とする、乳化剤の製造方法。  [8] A method for producing an emulsifier, comprising culturing red yeast in a culture solution, and separating and collecting a fraction containing the glycoprotein complex in the obtained culture solution. [9] 糖タンパク質複合体を含有する画分を分離及び回収することにより、ゲルろ過によつ て示される分子量が 30, 000以上の画分を得ることを特徴とする、請求項 8記載の製 造方法。  [9] The fraction according to claim 8, wherein a fraction having a molecular weight of 30,000 or more shown by gel filtration is obtained by separating and collecting a fraction containing the glycoprotein complex. Production method. [10] 請求項 1〜4のいずれかに記載の乳化剤と脂溶性物質を混合することを特徴とする、 水溶性組成物の製造方法。  [10] A method for producing a water-soluble composition, comprising mixing the emulsifier according to any one of claims 1 to 4 and a fat-soluble substance. [I I] 該脂溶性物質が、脂溶性薬物、ビタミン類、油脂、脂溶性色素、香料及びカロチノィ ドから選ばれる 1種以上である、請求項 10記載の製造方法。 [II] The fat-soluble substance contains fat-soluble drugs, vitamins, fats and oils, fat-soluble pigments, fragrances, and carotenoids. 11. The production method according to claim 10, wherein the production method is at least one selected from the group. 該脂溶性薬物がコェンザィム Q10であり、該ビタミン類がビタミン A、 D、 E、 K、及び それらの誘導体力 選ばれる 1種以上であり、該油脂が精油、植物油及び動物油か ら選ばれる 1種以上であり、該カロチノイドがカンタキサンチン、ァスタキサンチン、ゼ アキサンチン、リコピン、アポカロチナール及び j8—力ロチン力 選ばれる 1種以上で ある、請求項 11記載の製造方法。 The fat-soluble drug is Coenzyme Q10, the vitamins are one or more selected from vitamins A, D, E, K, and their derivatives, and the fat is selected from essential oils, vegetable oils and animal oils 12. The production method according to claim 11, wherein the carotenoid is at least one selected from canthaxanthin, austaxanthin, zeaxanthin, lycopene, apocarotinal and j8-power rotin power.
PCT/JP2006/302754 2005-02-17 2006-02-16 Emulsifying agent derived from red yeast Ceased WO2006088102A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005040524 2005-02-17
JP2005-040524 2005-02-17

Publications (1)

Publication Number Publication Date
WO2006088102A1 true WO2006088102A1 (en) 2006-08-24

Family

ID=36916503

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/302754 Ceased WO2006088102A1 (en) 2005-02-17 2006-02-16 Emulsifying agent derived from red yeast

Country Status (1)

Country Link
WO (1) WO2006088102A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103993062A (en) * 2014-04-03 2014-08-20 河南师范大学 Method for adopting Rhodotorula mucilaginosa to treat antibiotic fermentation wastewater so as to produce carotenoid
CN104844492A (en) * 2015-05-13 2015-08-19 威海利达生物科技有限公司 Method for extracting marine red shrimp astaxanthin from rhodotorula mucilaginosa

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5244781A (en) * 1975-10-07 1977-04-08 Idemitsu Kosan Co Ltd Emulsion stabilizing agent
JPH0578240A (en) * 1991-01-09 1993-03-30 Kanegafuchi Chem Ind Co Ltd Ubidecarenone-containing composition and its production
JPH10263385A (en) * 1997-03-17 1998-10-06 F Hoffmann La Roche Ag Microemulsion
JPH11342326A (en) * 1998-05-29 1999-12-14 Kirin Brewery Co Ltd Dispersion stabilizer

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5244781A (en) * 1975-10-07 1977-04-08 Idemitsu Kosan Co Ltd Emulsion stabilizing agent
JPH0578240A (en) * 1991-01-09 1993-03-30 Kanegafuchi Chem Ind Co Ltd Ubidecarenone-containing composition and its production
JPH10263385A (en) * 1997-03-17 1998-10-06 F Hoffmann La Roche Ag Microemulsion
JPH11342326A (en) * 1998-05-29 1999-12-14 Kirin Brewery Co Ltd Dispersion stabilizer

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103993062A (en) * 2014-04-03 2014-08-20 河南师范大学 Method for adopting Rhodotorula mucilaginosa to treat antibiotic fermentation wastewater so as to produce carotenoid
CN103993062B (en) * 2014-04-03 2016-08-31 河南师范大学 Rhodotorula mucilaginosa is utilized to process the method that antibiotic fermentation waste water produces carotenoid
CN104844492A (en) * 2015-05-13 2015-08-19 威海利达生物科技有限公司 Method for extracting marine red shrimp astaxanthin from rhodotorula mucilaginosa
CN104844492B (en) * 2015-05-13 2016-05-25 威海利达生物科技有限公司 A kind of method of extracting extra large red astaxanthin from rhodotorula mucilaginosa

Similar Documents

Publication Publication Date Title
TWI395596B (en) Emulsion composition
JP6121913B2 (en) Artificial oil body
EP1927287B1 (en) Emulsion composition, and foods and cosmetics containing the emulsion composition
KR102283331B1 (en) Fermented emulsifier using microorganism and preparation thereof
TW200932283A (en) Skin external preparation and method of producing the same
JP6580018B2 (en) Transparent lotion
JP6760685B2 (en) Manufacturing method of urolithins
Tiwari et al. Toward the formulation of bio-cosmetic nanoemulsions: from plant-derived to microbial-derived ingredients
JP4945692B2 (en) Cell-utilized skin external preparation composition and method for producing the same
EP1049455B1 (en) Cosmetic product based on artemia salina extracts for regenerating and stimulating skin cells
KR101622024B1 (en) Emulsifying agent comprising polysaccharide, cosmetic composition comprising the same, and method of producing thereof
KR20200093839A (en) Emulsifier composition comprising fermented microorganism and sodium surfatin and preparing method thereof
JP5273633B2 (en) emulsifier
JP6776437B2 (en) Underwater oil type cosmetics
JP4950511B2 (en) Emulsifier derived from red yeast
US8168618B2 (en) Emulsifying agent
EP1131047A1 (en) Oil bodies as topical delivery vehicles for active agents
WO2006088102A1 (en) Emulsifying agent derived from red yeast
KR20250114385A (en) Composition containing retinoid produced fermentatively, and method for preparing and using the same
CN116270319A (en) A kind of emulsion containing astaxanthin and preparation method thereof
JP2004067549A (en) External preparation for skin
KR101639467B1 (en) Novel microalgae of Odontella sp. and its use
KR102473157B1 (en) Nypa fruticans fruit fermented product applicable as halal cosmetic and cosmetic composition containing the same
JPH0741687A (en) Method for producing concentrated natural red pigment oil for food and concentrated natural red pigment oil for food
KR0123073B1 (en) Cosmetic composition containing bio-surfactant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06713895

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP